1. 0D biomaterials 2. Nanomaterials 3. Inductive properties 4. Magnetism 5. Ferromagnetism 6. Superparamagnetism 7. Nanoparticles 8. Magnetic nanoparticles 9. Biocompatible materials 10. Magneto-responsive 11. Magnetic resonance imaging (MRI) 12. Magnetic hyperthermia 13. Magnetic field 14. Electromagnetism 15. Biomedical applications 16. Nanotechnology 17. Magnetic nanostructures 18. Inductive heating 19. Magnetic susceptibility 20. Biomagnetism.
1. 1000 Genomes Project 1. Genetic sequence variation 2. Rare variants 3. Penetrance effects 4. Common variants 5. Genome mapping 6. Genetic variation 7. Large effect sizes 8. Rare genetic mutations 9. Genetic research 10. Genetic analysis 11. Genetic inheritance 12. Genetic disorders 13. Genetic epidemiology 14. Genetic association studies 15. Genetic variation databases 16. Genetic diversity 17. Genetic linkage 18. Genetic sequencing 19. Genetic polymorphisms 20. Genetic research projects.
1. UK 2. Abnormal PRP positivity 3. 2000 population 4. Blood test results 5. Platelet count 6. Platelet function tests 7. Coagulation disorders 8. Hemostasis 9. Hematology 10. Blood diseases 11. Diagnosis 12. Symptoms 13. Medical investigation 14. Laboratory tests 15. Blood disorders 16. Health screenings 17. Abnormal lab values 18. Medical conditions 19. Disease prevalence 20. Health statistics.
1. Perinatal mortality 2. Low birth weight 3. Infant mortality 4. Preterm birth 5. Birth weight 6. Fetal mortality 7. Neonatal mortality 8. Birth defects 9. Prematurity 10. Intrauterine growth restriction 11. Infant health 12. Birth complications 13. Perinatal health 14. Birth weight ratio 15. Small for gestational age 16. High risk pregnancy 17. Neonatal morbidity 18. Birth injury 19. Perinatal outcomes 20. Infant survival.
1. Vitamin B12 deficiency 2. Homocysteine levels 3. Hyperhomocysteinemia 4. Vitamin B12 absorption 5. Methylmalonic acid 6. Folate deficiency 7. Vitamin B6 8. Vitamin B9 (Folate) 9. Homocysteine metabolism 10. Cobalamin deficiency 11. Hydroxocobalamin 12. Methylcobalamin 13. Homocysteine-methionine cycle 14. Amino acid metabolism 15. Homocysteine-induced damage 16. Neurological symptoms 17. Cardiovascular disease risk 18. Renal function 19. Homocysteine-lowering therapies 20. Vitamin B12 supplementation.
1. Alpha thalassemia trait 2. Homozygous alpha thalassemia 3. Microerythrocytes 4. High microerythrocyte count 5. Anemia 6. Severe anemia 7. Vulnerability 8. Hemoglobin 9. Hb concentration 10. Red blood cells 11. Erythrocytes 12. Hemoglobinopathy 13. Hematology 14. Hematocrit 15. Hematological disorders 16. Genetic disorders 17. Thalassemia mutation 18. Hematological risk 19. Blood disorders 20. Clinical manifestations.
1. Asymptomatic carriers 2. VCJD infection 3. Variant Creutzfeldt-Jakob Disease 4. UK population 5. Prion disease 6. Transmission 7. Prevalence 8. Surveillance 9. Asymptomatic cases 10. Public health 11. Screening 12. Risk assessment 13. Sporadic cases 14. Neurodegenerative disorder 15. Human prion disease 16. Infectious disease 17. BSE (Bovine Spongiform Encephalopathy) 18. Human prion protein 19. Neurological symptoms 20. Diagnosis 21. Epidemiology 22. Public health measures 23. Transmission routes 24. Medical research 25. Neurology 26. Neuropsychology 27. Neuroimaging 28. Neuropathology 29. Neuroprotection 30. Neuroinfectiology.
1. Adar1 (ADAR1, Alcohol Dehydrogenase Quasi-Reverse Transcriptase 1) 2. Dicer (RNase III endonuclease) 3. Pre-miRNA (pri-miRNA, primary miRNA) 4. miRNA (microRNA) 5. RNA binding protein 6. Cleavage 7. Pre-processing 8. miRNA biogenesis 9. RNA interference 10. Post-transcriptional regulation 11. RNA modification 12. ADAR1-Dicer interaction 13. RNA editing 14. dsRNA binding 15. RNA metabolism 16. RNA splicing 17. RNA degradation.
1. Aire protein 2. Skin tumors 3. Autoimmune regulator gene (Aire) 4. Expression 5. Skin conditions 6. Immunology 7. Melanoma 8. Basal cell carcinoma 9. Squamous cell carcinoma 10. Cutaneous T-cell lymphoma 11. Autoimmunity 12. Cancer 13. Genetics 14. Molecular biology 15. Tumor markers 16. Immunosuppression 17. Dermatology 18. Epithelial tumors 19. Thymus gland 20. Endocrine system.
1. Aldh1 (Aldehyde Dehydrogenase 1) 2. Breast Cancer 3. Outcomes 4. Prognosis 5. Survival 6. Markers 7. Biomarkers 8. Cancer Stem Cells 9. Epithelial-to-Mesenchymal Transition (EMT) 10. Chemosensitivity 11. Resistance 12. Apoptosis 13. Metastasis 14. Tumor Initiation 15. Aldehyde Metabolism 16. Cancer Progression 17. Aldehyde Detoxification 18. Aldehyde Oxidase 19. Cancer Therapy 20. Aldh1 Expression Level 21. Aldh1 Activity 22. Breast Tumors 23. Clinical Trials 24. Diagnosis 25. Treatment.
1. Aldh1 (Aldehyde Dehydrogenase 1) 2. Breast Cancer 3. Prognosis 4. Poor Prognosis 5. Expression 6. Cancer Markers 7. Biomarkers 8. Aldehyde Dehydrogenase 9. Cancer Stem Cells 10. Epithelial-Mesenchymal Transition (EMT) 11. Chemo-Resistance 12. Tumor Progression 13. Survival Rate 14. Recurrence 15. Apoptosis 16. Metastasis 17. Aldehyde Metabolism 18. Aldehyde Oxidase 19. Cancer Therapy 20. Aldh1 Inhibitors.
1. AMP-activated protein kinase (AMPK) 2. AMPK activation 3. Inflammation 4. Fibrosis 5. Lungs 6. AMPK and fibrosis 7. AMPK and inflammation 8. Lung fibrosis 9. AMPK signaling 10. Inflammatory response 11. Lung inflammation 12. AMPK regulation 13. Fibrotic process 14. AMPK and cytokines 15. Lung fibroblasts 16. AMPK and TGF-β 17. AMPK and oxidative stress 18. AMPK and inflammatory mediators 19. AMPK and fibrosis markers 20. Lung tissue remodeling 21. AMPK and apoptosis 22. AMPK inhibitors 23. AMPK and inflammatory pathways 24. AMPK and fibrosis animal models 25. AMPK and lung function.
1. APOE4 expression 2. iPSC-derived neurons 3. Alpha-beta production 4. Tau phosphorylation 5. GABA neurons 6. Neuron degeneration 7. Alzheimer's disease 8. Protein misfolding 9. Neurotoxicity 10. Neurodegenerative disorders 11. Neuroprotection 12. APOE4 genotype 13. Neuronal differentiation 14. Neuroinflammation 15. Neuroimaging 16. Biomarkers 17. Neurotransmission 18. Synaptic function 19. Neurodevelopment 20. Neuroplasticity.
1. APOE4 expression 2. iPSC (induced Pluripotent Stem Cell) derived neurons 3. Alzheimer's beta production 4. Tau phosphorylation 5. GABA neuron degeneration 6. Neuron differentiation 7. Alzheimer's disease 8. Neuroprotection 9. Neurodegeneration 10. Protein expression 11. Neurobiology 12. Neuroscience 13. APOE gene 14. Neuropharmacology 15. Neurotoxicity 16. Neuroimaging 17. Neurochemistry 18. Neuroinflammation 19. Protein modification 20. Neuroregeneration.
1. PPM1d (protein phosphatase 1, catalytic subunit delta) 2. Activation (of PPM1d) 3. Suppression (of p53 function) 4. p53 (tumor suppressor protein) 5. Phosphatase (activity) 6. Protein-protein interactions 7. Cell cycle regulation 8. Apoptosis (programmed cell death) 9. DNA damage response 10. Tumor suppression 11. Oncogenesis (cancer development) 12. Cell signaling 13. Post-translational modifications (PTMs) 14. Phosphorylation (of p53) 15. MDM2 (E3 ubiquitin ligase) 16. Inhibition (of p53) 17. Cancer therapy 18. Molecular mechanisms 19. Gene expression 20. Nuclear localization (of p53) 21. Transcriptional regulation.
1. Activator-inhibitor pairs 2. ADMP (Adipose Derived Mesenchymal Progenitor) cells 3. Chordin 4. Dorsal region 5. Inhibitors 6. Signaling pathways 7. Bone development 8. Cartilage development 9. TGF-β (Transforming Growth Factor-beta) 10. BMPs (Bone Morphogenic Proteins) 11. Follistatin 12. Noggin 13. Antagonists 14. Developmental biology 15. Cellular signaling 16. Regulatory proteins 17. Growth factors 18. Anabolic processes 19. Skeletal development.
1. H. pylori 2. Urease 3. Active site 4. Polymeric structure 5. Subunits 6. Urea 7. Ureb 8. Enzyme 9. Cofactor 10. Proton pump 11. Nickel ion 12. Biochemistry 13. Microbiology 14. Gastric infection 15. Protein structure 16. Enzyme mechanism 17. Catalytic activity 18. Urease inhibitors 19. Urease assay 20. Urease gene.
1. Albendazole 2. Lymphatic filariasis 3. Anthelmintic 4. Parasitic infection 5. Microfilaria 6. Worm infestation 7. Tropical disease 8. Neglected tropical disease 9. Mass drug administration 10. Filariasis treatment 11. Antiparasitic drug 12. Albendazole tablet 13. Albendazole dosage 14. Albendazole side effects 15. Albendazole for filariasis 16. Albendazole mechanism of action 17. Albendazole resistance 18. Albendazole administration 19. Albendazole contraindications 20. Albendazole interaction with other drugs.
1. Alizarin 2. Hydrogen bonds 3. Residues 4. PGAM1 (Phosphoglycerate mutase 1) 5. Substrate binding 6. Phosphoglycerate mutase 7. Protein-ligand interaction 8. Biochemistry 9. Molecular binding 10. Hydrogen bonding interactions 11. PGAM1 active site 12. Substrate recognition 13. Protein structure 14. Ligand docking 15. Molecular modeling 16. Biological binding 17. PGAM1 catalysis 18. Alizarin binding site 19. Protein-ligand complex 20. Hydrogen bond donors and acceptors.
1. Hematopoietic stem cells 2. Chromosomes 3. Segregation 4. Random process 5. Genetics 6. Mitosis 7. Meiosis 8. Cell division 9. Chromatid separation 10. Sister chromatids 11. Homologous chromosomes 12. Independent assortment 13. Genetic recombination 14. DNA replication 15. Chromosome number 16. Stem cell biology 17. Cell lineage 18. Hematopoiesis 19. Chromosome theory 20. Mendelian genetics.
1. Angiotensin Converting Enzyme (ACE) inhibitors 2. Functional Renal Insufficiency 3. Renal Function 4. Kidney Dysfunction 5. Side Effects 6. Adverse Reactions 7. Nephropathy 8. Acute Renal Failure 9. Chronic Kidney Disease 10. Proteinuria 11. Creatinine 12. Blood Urea Nitrogen (BUN) 13. Renin-Angiotensin-Aldosterone System (RAAS) 14. Hypertension 15. Cardiovascular Disease 16. Elderly population 17. Diabetes 18. Drug toxicity 19. Dose-dependent risk 20. Long-term use.
1. Anthrax spores 2. Dispersal 3. Disposal 4. Decontamination 5. Bioterrorism 6. Safety measures 7. Hazardous materials 8. Environmental safety 9. Cleanup 10. Sterilization 11. Decontamination methods 12. Spore inactivation 13. Disinfection 14. Containment 15. Public health 16. Risk assessment 17. Emergency response 18. Biohazard waste 19. Regulations 20. Guidelines.
1. Antibiotic-induced alterations 2. Antibiotic treatment 3. Gut microbiome 4. Clostridium difficile 5. Antibiotic resistance 6. Microbial imbalance 7. Dysbiosis 8. Intestinal microbiota 9. Antibiotic-associated diarrhea 10. Clostridioides difficile infection 11. Fecal microbiota transplant 12. Probiotics 13. Antibiotic-resistant bacteria 14. Intestinal colonization 15. Antibiotic-induced gut damage 16. Microbial diversity 17. Intestinal homeostasis 18. Intestinal permeability 19. Antibiotic-induced gut inflammation.
1. Antiretroviral therapy (ART) 2. Tuberculosis (TB) 3. CD4 count 4. HIV/AIDS 5. Reduces rates 6. Prevention 7. Broad range 8. CD4 strata 9. HIV infection 10. TB incidence 11. Antimicrobial therapy 12. HIV treatment 13. TB co-infection 14. Epidemiology 15. Public health 16. Primary prevention 17. Secondary prevention 18. Clinical trials 19. Pharmacology 20. Co-morbidities.
1. Arginine 2. Arginine 90 3. P150n protein 4. EB1 protein 5. Interaction 6. Protein-protein interaction 7. Arginine residue 8. Post-translational modification 9. Modification of P150n 10. EB1 function 11. Microtubule dynamics 12. Cell division 13. Mitosis 14. Protein binding 15. Arginine side chain 16. Arginine methylation 17. Arginine modification 18. Protein regulation 19. Cell signaling 20. Arginine-rich motif.
1. Arterioles 2. Venules 3. Lumen diameter 4. Blood vessels 5. Capillaries 6. Vessel size 7. Blood flow 8. Circulatory system 9. Arterial system 10. Venous system 11. Microcirculation 12. Vascular diameter 13. Blood pressure 14. Resistance vessels 15. Peripheral circulation 16. Blood pressure regulation 17. Blood vessel walls 18. Endothelial cells 19. Blood vessel dilation 20. Blood vessel constriction.
1. Open access articles 2. Citation rates 3. Traditional journals 4. Scholarly publications 5. Accessibility 6. Peer-reviewed journals 7. Impact factor 8. Research output 9. Academic journals 10. Open science 11. Visibility 12. Access barriers 13. Publication venues 14. Research dissemination 15. Open access policy 16. Bibliometric analysis 17. Scholarly communication 18. Online journals 19. Accessibility and usage 20. Free access publications.
1. Open access 2. Articles 3. Citations 4. Traditional journals 5. Scholarly publications 6. Peer-reviewed 7. Research output 8. Impact factor 9. Accessibility 10. Online journals 11. Open science 12. Academic publications 13. Electronic journals 14. Open access databases 15. Citation advantage 16. Open access policy 17. Visibility and discoverability 18. Open access repository 19. Access to research 20. Open access funding.
1. Aspirin 2. PGE2 (Prostaglandin E2) 3. Inhibition 4. Production 5. Non-steroidal anti-inflammatory drugs (NSAIDs) 6. Cyclooxygenase (COX) 7. Prostaglandins 8. Anti-inflammatory 9. Acetylsalicylic acid 10. Prostaglandin synthesis 11. Inflammation 12. Pain relief 13. Anti-fever 14. Platelet aggregation 15. COX-1 and COX-2 enzymes 16. Selective inhibition 17. Pharmacology 18. Therapeutic agents 19. Cardiovascular health 20. Gastrointestinal side effects.
1. Assembly of invadopodia 2. Focal generation 3. Phosphatidylinositol 3 4 biphosphate (PI(3,4)P2) 4. Nonreceptor tyrosine kinase 5. Src 6. Invadopodia activation 7. Signal transduction 8. Phosphoinositide signaling 9. Tyrosine kinase activation 10. Cell invasion 11. Membrane protrusions 12. Cell motility 13. Phospholipids 14. Cell signaling 15. Cell migration 16. Focal adhesion 17. Rho GTPases 18. Actin dynamics 19. Matrix degradation 20. Cell-matrix interactions.
1. Asymptomatic visual impairment 2. Elderly populations 3. Screening 4. Visual acuity 5. Improved vision 6. No effect 7. No benefit 8. Sensory impairment 9. Age-related eye diseases 10. Ophthalmology 11. Prevention 12. Early detection 13. Eye examinations 14. Healthy aging 15. Eye care 16. Refractive error 17. Cataracts 18. Macular degeneration 19. Glaucoma 20. Retinal diseases.
1. Auditory entrainment 2. Visual and auditory information 3. Congruent stimuli 4. Sensory integration 5. Neural synchronization 6. Brainwave synchronization 7. Multisensory processing 8. Audiovisual perception 9. Synesthesia 10. Attention and focus 11. Cognitive processing 12. Neuroplasticity 13. Sensory interaction 14. Perceptual coordination 15. Multimodal stimuli 16. Synchronization of brain rhythms 17. Auditory and visual cues 18. Multisensory integration theory 19. Sensory fusion 20. Auditory and visual perception overlap.
1. Autologous transplantation 2. Mesenchymal stem cells 3. Opportunistic infections 4. Induction therapy 5. Anti-interleukin 2 receptor antibodies 6. Immunosuppression 7. Graft-versus-host disease 8. Infection risk 9. Stem cell transplant 10. Immunocompromised patients 11. Fungal infections 12. Bacterial infections 13. Viral infections 14. Post-transplant complications 15. Immunological response 16. Immunosuppressive drugs 17. Transplant outcomes 18. Infection prevention 19. Immunological side effects.
1. Autologous transplantation 2. Mesenchymal stem cells 3. Opportunistic infections 4. Anti-interleukin 2 receptor antibodies 5. Induction therapy 6. Immunosuppression 7. Stem cell transplant 8. Graft-versus-host disease 9. Infection prevention 10. Immunocompromised patients 11. Antibody therapy 12. Interleukin 2 receptor 13. Immunological response 14. Fewer infections 15. Immunosuppressive agents 16. Risk reduction 17. Transplant complications 18. Immunological suppression 19. Infection rate 20. Stem cell therapy.
1. Autologous transplantation 2. Mesenchymal stem cells 3. Rejection rates 4. Lower rates 5. Induction therapy 6. Anti-interleukin 2 receptor antibodies 7. Immunosuppression 8. Stem cell transplantation 9. Allogeneic transplantation 10. Graft-versus-host disease 11. Immunocompatibility 12. Anti-rejection therapy 13. Immunosuppressive drugs 14. Transplant complications 15. Immunology 16. Mesenchymal stem cell therapy 17. Immunosuppressive agents 18. Anti-rejection medications 19. Immunological response 20. Transplant outcomes.
1. Autophagy 2. Aging 3. Organisms 4. Senescence 5. Cellular aging 6. Lysosomes 7. Degradation 8. Autophagic flux 9. Cellular maintenance 10. Aging process 11. Autophagic degradation 12. Cellular recycling 13. Aging-related decline 14. Autophagosomes 15. Autolysosomes 16. Protein degradation 17. Cellular housekeeping 18. Aging-induced changes 19. Cellular metabolism 20. Autophagy dysfunction.
1. Bariatric surgery 2. Mental health 3. Positive impact 4. Weight loss 5. Depression 6. Anxiety 7. Self-esteem 8. Emotional well-being 9. Psychological benefits 10. Stress reduction 11. Mood improvement 12. Quality of life 13. Body image 14. Self-confidence 15. Mood disorders 16. Obesity 17. Comorbidities 18. Emotional eating 19. Mental health disorders 20. Post-surgery adjustment.
1. Basophils 2. Systemic Lupus Erythematosus (SLE) 3. Disease development 4. Counteract 5. Immunity 6. Inflammation 7. Autoimmune response 8. Leukocytes 9. Granulocytes 10. Mediators 11. Allergic reactions 12. Histamine 13. Cytokines 14. Interleukins 15. Heparin 16. Complement system 17. Apoptosis 18. Regulation 19. Therapy 20. Treatment 21. Clinical trials 22. Biomarkers 23. Diagnosis 24. Prognosis 25. Symptoms 26. Pathology 27. Neutrophils 28. Eosinophils 29. Platelets 30. Hemostasis.
1. Birth weight 2. Breast cancer 3. Positive association 4. Correlation 5. Risk factor 6. Infant health 7. Childhood growth 8. Epidemiology 9. Oncology 10. Cancer research 11. Prevention 12. Childhood development 13. Hormones 14. Obesity 15. Cancer risk 16. Gestational weight gain 17. Fetal growth 18. Body weight 19. Health outcomes 20. Long-term health effects.
1. TDP-43 (TAR DNA-binding protein 43) 2. Respiratory complex I 3. Proteins ND3 and ND6 4. Interaction blocking 5. Neuronal loss 6. TDP-43 induced neuronal damage 7. Complex I proteins 8. Neurodegeneration 9. TDP-43 and Complex I 10. Protein inhibition 11. Neuroprotection 12. Neurotoxicity 13. TDP-43 and ND3 14. TDP-43 and ND6 15. Complex I dysfunction 16. TDP-43 and Complex I interaction 17. Neuronal survival 18. Neurobiology 19. Protein interaction 20. Neuroscience 21. TDP-43 and neurodegenerative diseases.
1. Bone Marrow Cells 2. Macrophages 3. Adult Macrophages 4. Hematopoiesis 5. Mononuclear Cells 6. Monocytes 7. Granulocyte-Monocyte Colony-Stimulating Factor (GM-CSF) 8. Monocyte-Macrophage Differentiation 9. Hemopoiesis Compartments 10. Phagocytosis 11. Immune System 12. Hematopoietic Stem Cells 13. Myeloid Cells 14. Tissue Macrophages 15. Monocyte Chemotactic Protein-1 (MCP-1) 16. Macrophage Colony-Stimulating Factor (M-CSF) 17. Macrophage Development 18. Hemopoietic Progenitor Cells 19. Bone Marrow Niche 20. Macrophage Renewal.
1. Breast cancer 2. Genetic factors 3. Hereditary breast cancer 4. Mutations 5. BRCA1 gene 6. BRCA2 gene 7. TP53 gene 8. Lynch syndrome 9. Familial breast cancer 10. Inherited predisposition 11. Germline mutations 12. Cancer susceptibility genes 13. Oncogenes 14. Tumor suppressor genes 15. Genetic testing 16. Inheritance patterns 17. Penetrance 18. Risk assessment 19. Genetic counseling 20. Family history 21. High-risk populations 22. Monogenic inheritance 23. Cancer predisposition 24. Genetic determinism 25. Somatic mutations.
1. CCL19 (C-C chemokine ligand 19) 2. Absent 3. DLNs (Draining Lymph Nodes) 4. Chemokine 5. Lymph Nodes 6. Immunology 7. Cytokine 8. Inflammation 9. Chemotaxis 10. Lymphocytes 11. T-cells 12. B-cells 13. Immun response 14. Antigen presentation 15. Immun deficiency 16. Immunology research 17. Immunopathology 18. Inflammatory response 19. Immunology experiments 20. Immunohistochemistry.
1. Chek2 gene 2. Breast cancer 3. No association 4. Genetic marker 5. Risk factor 6. Variant 7. Polymorphism 8. Mutation 9. Breast cancer susceptibility 10. Chek2 and breast cancer risk 11. Chek2 and breast cancer link 12. Chek2 and breast cancer studies 13. Chek2 and breast cancer research 14. Chek2 and breast cancer prevention 15. Chek2 and breast cancer diagnosis 16. Chek2 and breast cancer treatment 17. Chek2 and breast cancer prognosis 18. Chek2 and breast cancer mortality 19. Chek2 and breast cancer survival 20. Chek2 and breast cancer screening.
1. CR (Caloric Restriction) 2. Methylation Age 3. Epigenetic Markers 4. DNA Methylation 5. Aging Process 6. Biomarkers of Aging 7. Epigenetic Clock 8. Epigenetics 9. Caloric Restriction and Aging 10. Methylation Patterns 11. Epigenetic Modifications 12. Aging Biomarkers 13. Epigenetic Aging 14. Methylation Levels 15. CR and Methylation Age Association 16. Epigenetic Regulation 17. Methylation and Caloric Restriction 18. Epigenetic Changes in Aging 19. Methylation Markers 20. CR and Epigenetic Aging.
1. CRP (C-reactive protein) 2. Postoperative mortality 3. Coronary artery bypass graft (CABG) surgery 4. Predictive value 5. Inflammation marker 6. Cardiac surgery 7. Outcomes research 8. Perioperative period 9. Morbidity and mortality 10. Prognostic factors 11. Surgical complications 12. Clinical studies 13. Epidemiology 14. Risk assessment 15. C-reactive protein levels 16. Cardiovascular disease 17. Postoperative recovery 18. Statistical analysis 19. Multivariate analysis 20. Prognostic significance.
1. CX3CR1 (C-X-C chemokine receptor type 1) 2. Th2 cells (T helper 2 cells) 3. T cell survival 4. Impairment 5. Chemokine receptor 6. Signaling 7. Apoptosis (programmed cell death) 8. Cytokines 9. Immunology 10. Inflammation 11. T cell activation 12. T cell proliferation 13. T cell differentiation 14. T cell function 15. Immunosuppression 16. CX3CL1 (Fractalkine) 17. Receptor-ligand interaction 18. Immunopathology 19. Hematopoiesis 20. Lymphocytes.
1. CX3CR1 (C-X-C chemokine receptor type 1) 2. Th2 cells (T helper 2 cells) 3. T cell survival 4. Promotes (enhances, facilitates) 5. Chemokine receptor 6. Immunology 7. Inflammation 8. T cell signaling 9. Cytokines 10. Survival signaling 11. Immunoregulation 12. T cell activation 13. Th2 response 14. CX3CL1 (Fractalkine) 15. Chemokine ligand 16. T cell interaction 17. Cellular communication 18. Immunosuppression 19. T cell differentiation 20. Innate immunity.
1. CX3CR1 (C-X-C chemokine receptor type 1) 2. Th2 cells (T helper 2 cells) 3. Airway inflammation 4. Chemokines 5. CX3CL1 (C-X-3-C chemokine ligand 1) 6. Immune response 7. Allergic response 8. Inflammatory cytokines 9. T cell activation 10. Respiratory system 11. Asthma 12. Chronic inflammation 13. Signaling pathways 14. Migration of immune cells 15. Immunomodulation 16. Airway remodeling 17. Inflammatory mediators 18. Lung inflammation 19. Immunology 20. Cytokine network.
1. CX3CR1 (C-X-C chemokine receptor type 1) 2. Th2 cells (T helper 2 cells) 3. Airway inflammation 4. Suppression 5. Immunomodulation 6. Chemokine signaling 7. Inflammatory response 8. Allergic reaction 9. Lung inflammation 10. Cytokines 11. Immunoregulation 12. T cell activation 13. Airway remodeling 14. Asthma 15. Anti-inflammatory effects 16. CX3CL1 (Fractalkine) 17. Immunotherapy 18. Respiratory system 19. Inflammatory mediators 20. Chemotaxis.
1. Alcohol dehydrogenase deficiency 2. Carriers (of the mutation) 3. Alcohol aldehyde dehydrogenase 4. Mutation 5. Alcohol consumption 6. Drink less 7. Non-carriers 8. Alcohol metabolism 9. Aldehyde dehydrogenase 10. Genetic predisposition 11. Alcohol sensitivity 12. Haplotypes 13. Alcohol intolerance 14. Alcohol metabolizing enzymes 15. Alcohol-related health issues.
1. Cataract 2. Trachoma 3. Blindness 4. Southern Sudan 5. Primary cause 6. Eye diseases 7. Vision loss 8. Ophthalmology 9. Preventive health 10. Public health 11. Eye care 12. Infectious diseases 13. Chronic conditions 14. Health disparities 15. Global health 16. Eye infections 17. Eye health 18. Blindness prevention 19. Eye treatment 20. Eye surgery 21. Eye care access 22. Eye health campaigns 23. Eye care services 24. Eye health education 25. Eye care funding.
1. Cell autonomy 2. Sex determination 3. Galliformes (gamebirds) 4. Somatic cells 5. Sex differentiation 6. Gallus gallus (chicken) 7. Avian species 8. Gonads 9. Genetic sex determination 10. Epigenetic modifications 11. Sex chromosomes 12. Sexual development 13. Bird embryology 14. Hormonal influences 15. Sexual dimorphism 16. Chromosomal sex 17. Environmental factors 18. Sexual identity 19. Sexual development in birds 20. Galliformes sex determination.
1. Cell autonomy 2. Sex determination 3. Somatic cells 4. Passeriformes (birds) 5. Avian development 6. Sex differentiation 7. Gonads 8. Genetic sex determination 9. Epigenetic modifications 10. Sex chromosomes 11. Sex determination genes 12. Bird embryology 13. Sexual dimorphism 14. Wiltshire effect 15. ZW system 16. Sex-determining region Y (SRY) 17. DNA methylation 18. Histone modifications 19. Non-genetic factors 20. Cellular signaling.
1. Bacillus subtilis 2. Cells 3. Clpc (Chloramphenicol acetyltransferase, a protein involved in sporulation) 4. Defect 5. Sporulation 6. Efficiency 7. Chloramphenicol 8. Acetyltransferase 9. Protein 10. Gene expression 11. Development 12. Spore formation 13. Genetics 14. Microbiology 15. Bacterial sporulation 16. Cell cycle 17. Regulation 18. Mutation 19. Sporulation defects 20. Gene regulation.
1. Methionine restriction 2. Cells 3. Activate 4. miRNAs (microRNAs) 5. Post-transcriptional gene regulation 6. Nutrient deprivation 7. Metabolism 8. Small non-coding RNAs 9. Gene expression 10. RNA interference 11. Epigenetic modifications 12. Translation inhibition 13. mTOR signaling pathway 14. Autophagy 15. Cellular stress response 16. Ribosome biogenesis 17. Protein synthesis 18. Cellular senescence 19. Apoptosis 20. Cellular metabolism reprogramming.
1. Cellular aging 2. Aging process 3. Senescence 4. Telomere shortening 5. Wrinkles 6. Sagging skin 7. Age spots 8. Fine lines 9. Skin texture 10. Epigenetic changes 11. Free radical damage 12. Collagen production 13. Elastin fibers 14. Cellular senescence markers 15. Mitochondrial dysfunction 16. Age-related diseases 17. Gerontology 18. Biological aging 19. Appearance 20. Older look.
1. Chenodeoxycholic acid (CDCA) 2. Treatment 3. Whole body energy expenditure 4. Metabolism 5. Thermogenesis 6. Calories burned 7. Basal metabolic rate 8. Energy homeostasis 9. Lipid metabolism 10. Cholesterol 11. Bile acids 12. Obesity 13. Weight loss 14. Fasting 15. Hepatocellular nuclear factor 4α (HNF4α) 16. Peroxisome proliferator-activated receptors (PPARs) 17. Adipose tissue 18. Brown adipose tissue (BAT) 19. White adipose tissue (WAT) 20. Adipocytes 21. Energy balance 22. Nutrition 23. Clinical trials 24. Pharmacology 25. Endocrinology 26. Diabetes 27. Insulin sensitivity 28. Hyperlipidemia 29. Hep
1. Chenodeoxycholic acid 2. Treatment 3. Whole body energy expenditure 4. Metabolism 5. Liver function 6. Thyroid hormones 7. Basal metabolic rate 8. Energy homeostasis 9. Lipid metabolism 10. Cholesterol 11. Bile acids 12. Obesity 13. Weight loss 14. Hepatology 15. Pharmacology 16. Nutrition 17. Fasting 18. Caloric intake 19. Adipose tissue 20. Insulin sensitivity.
1. Chronic aerobic exercise 2. Endothelial function 3. Vasodilating mechanisms 4. Nitric oxide (NO) 5. Endothelium 6. Blood vessels 7. Vasodilation 8. Aerobic training 9. Cardiovascular health 10. Endothelial dysfunction 11. Nitric oxide synthesis 12. Vasodilators 13. Blood flow 14. Exercise-induced adaptations 15. Endothelial nitric oxide synthase (eNOS) 16. Vascular endothelial growth factor (VEGF) 17. Vascular smooth muscle cells 18. Arteries 19. Veins 20. Capillaries.
1. Cold exposure 2. Bat recruitment 3. Hibernation 4. Temperature 5. Torpor 6. Bat conservation 7. Bat population 8. Thermoregulation 9. Winter survival 10. Bat behavior 11. Environmental factors 12. Bat habitat 13. Bat migration 14. Bat roosts 15. Bat activity 16. Bat research 17. Bat physiology 18. Bat adaptation 19. Cold weather 20. Bat hibernation sites.
1. Cold exposure 2. Bat recruitment 3. Temperature 4. Hibernation 5. Bat population 6. Bat conservation 7. Thermoregulation 8. Bat behavior 9. Environmental factors 10. Bat colonies 11. Climate change 12. Bat survival 13. Bat migration 14. Bat roosting sites 15. Bat productivity 16. Bat reproduction 17. Bat health 18. Bat development 19. Cold temperatures 20. Bat habitat.
1. Nicotine replacement therapies (NRT) 2. Varenicline 3. Bupropion 4. Combination therapy 5. Long-term abstinence 6. Smoking cessation 7. Quit smoking 8. 52-week study 9. Higher abstinence rates 10. NRT and varenicline 11. NRT and bupropion 12. Nicotine patch 13. Nicotine gum 14. Nicotine lozenge 15. Nicotine inhaler 16. Nicotine replacement medication 17. Smoking medication 18. Tobacco cessation 19. Quit smoking medication 20. Pharmacotherapy 21. Smoking addiction 22. Nicotine addiction 23. Smoking treatment 24. Tobacco treatment 25. Evidence-based treatment 26. Randomized controlled trial 27. Clinical trial 28. Smoking cessation success 29. Smoking cessation outcomes 30. Nicotine
1. KRAS mutant tumors 2. Kinase inhibitors 3. Mek1 inhibitors 4. Mek2 inhibitors 5. Combination therapy 6. Triple inhibition 7. KRAS signaling pathway 8. Oncology 9. Cancer treatment 10. Anticancer agents 11. Signal transduction 12. MEK-ERK pathway 13. Apoptosis 14. Cancer cell growth 15. Tumor suppression 16. Targeted therapy 17. KRAS mutations 18. Molecular targeted therapy 19. Anticancer drugs 20. Chemotherapy combination 21. Pharmacology 22. Clinical trials 23. Cancer research 24. Personalized medicine 25. Cancer therapy development.
1. Commelina yellow mottle virus (CymMV) 2. Comymv 3. Virus genome 4. Commelina mottle virus 5. RNA virus 6. Single-stranded RNA 7. Viral genome sequence 8. Base pairs 9. Nucleotides 10. Genome size 11. Commelina 12. Yellow mottle disease 13. Viral replication 14. Viral structure 15. Viral protein 16. Genomic sequence 17. RNA viruses, plant 18. Plant virology 19. Commelina yellow mottle virus genome 20. Genome analysis 21. Viral genetics 22. Virus structure and function 23. Viral genome organization 24. Molecular biology 25. RNA viruses, structure and replication.
1. Crossover hot spots 2. Saccharomyces cerevisiae 3. Gene promoters 4. Genetic recombination 5. DNA crossover 6. Genomic regions 7. Crossing over 8. Gene regulation 9. Transcription start sites 10. Recombination hotspots 11. Chromosome segregation 12. Meiosis 13. Mitosis 14. Molecular biology 15. Genetics 16. DNA structure 17. Gene expression 18. Transcription 19. Epigenetics 20. Sequence analysis.
1. Dendritic Cells (DCs) 2. Innate Lymphoid Cells (ILCs) 3. Intestinal Homeostasis 4. Crosstalk 5. Regulation 6. Immune Response 7. Intestinal Immune System 8. Intestinal Mucosa 9. Intestinal Epithelium 10. Immune Signaling 11. Immune Communication 12. Immunity 13. Inflammation 14. Intercellular Interactions 15. Immunological Synapse 16. Immune Activation 17. Innate Immunity 18. Adaptive Immunity 19. Intestinal Barrier 20. Intestinal Inflammation 21. Gut-Associated Lymphoid Tissue (GALT) 22. Intestinal Microbiota 23. Immunological Tolerance 24. Immunoregulation.
1. Cytochrome c 2. Apoptosis 3. Mitochondria 4. Intermembrane space 5. Cytosol 6. Release 7. Apoptotic process 8. Programmed cell death 9. Mitochondrial outer membrane permeabilization (MOMP) 10. Caspases 11. Apoptosome 12. Apoptotic signaling 13. Bcl-2 family proteins 14. Proapoptotic proteins 15. Mitochondrial dysfunction 16. Apoptotic mitochondria 17. Cell death 18. Apoptotic pathway 19. Apoptotic proteins 20. Mitochondrial inner membrane.
1. Cytosolic proteins 2. Iron responsive elements (IREs) 3. mRNAs 4. DMT1 (Dietary Iron Transporter 1) 5. Iron uptake 6. Proteins 7. Transcription factors 8. Regulation 9. Iron homeostasis 10. Post-transcriptional modification 11. RNA binding proteins 12. Iron-regulated genes 13. Iron-responsive proteins 14. Iron metabolism 15. Iron transport 16. Iron-sulfur clusters 17. Ferric response elements (FREs) 18. Iron-responsive elements binding (IREB) 19. Iron-regulated translation 20. Iron-responsive protein translation.
1. DMRT1 gene 2. Sex determining gene 3. Epigenetic regulation 4. Mhm region 5. Gene expression 6. DNA methylation 7. Histone modification 8. Chromatin structure 9. Sex differentiation 10. Epigenetic marks 11. Epigenetics 12. Gene regulation 13. Sex chromosomes 14. Epigenetic modifications 15. Sex determination 16. Epigenetic markers 17. DNA methyltransferases 18. Histone deacetylases 19. Histone acetyltransferases 20. Epigenetic inheritance.
1. De novo assembly 2. Sequence data 3. Contigs 4. Specific contigs 5. Unassembled sequence data 6. Genome assembly 7. Sequencing technology 8. Read length 9. Overlapping reads 10. Sequence alignment 11. Contig length 12. Contig N50 13. Contig coverage 14. Sequencing error correction 15. Assembly quality 16. Genome finishing 17. Scaffolding 18. Gap closing 19. Sequencing depth 20. Long read sequencing 21. Short read sequencing 22. Hybrid assembly 23. Improved contigs 24. Consensus sequences 25. Sequence overlap 26. Genome structure 27. Genome annotation 28. Sequence analysis 29. Genome comparison 30. Genome evolution.
1. Deamination 2. Cytidine 3. Uridine 4. Minus strand 5. Viral DNA 6. Catastrophic mutations 7. G to A transitions 8. Base modification 9. DNA replication 10. Viral genome 11. Mutagenesis 12. Apurinic/apyrimidinic sites 13. DNA damage 14. Error prone replication 15. Replicative bypass 16. Viral replication 17. Mutation rate 18. Ganciclovir 19. Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) 20. Deoxycytidine deaminase (dCDA) 21. Error catastrophe 22. Double-stranded RNA viruses 23. Single-stranded RNA viruses 24. Retroviruses 25. Reverse transcription.
1. Raptor protein 2. GCFS (Granulocyte Colony-Stimulating Factor) 3. Protein depletion 4. Reduction in GCFS levels 5. Immunology 6. Cytokines 7. Hematopoiesis 8. Apoptosis (programmed cell death) 9. Signal transduction 10. Cellular response 11. Inflammation 12. Hematopoietic stem cells 13. Blood cell production 14. Regulation of GCFS 15. Cell signaling 16. Molecular biology 17. Raptor knockdown 18. GCFS expression 19. Immunological response 20. Receptor-associated protein of mTOR complex 2 (Raptor) 21. mTOR complex 22. Cellular signaling pathways 23. GCFS-related research 24. Cellular homeostasis 25. Cellular processes.
1. Deletion of V8 gene 2. V8 gene mutation 3. Inflammatory phenotype 4. Spontaneous inflammation 5. Genetic deletion 6. V8 protein 7. Inflammatory response 8. Gene function 9. Absence of V8 protein 10. Immunology 11. Inflammation markers 12. Genetic modification 13. V8 deficiency 14. Inflammatory disease 15. Gene expression 16. Vascular endothelial growth factor 17. Angiogenesis 18. Inflammatory signaling 19. Vascular biology 20. Gene therapy.
1. Dexamethasone 2. Postoperative bleeding 3. Risk reduction 4. Steroid 5. Anti-inflammatory 6. Surgical procedure 7. Hemorrhage 8. Coagulation 9. Hormone therapy 10. Perioperative care 11. Wound healing 12. Blood loss 13. Prevention 14. Corticosteroid 15. Thrombosis 16. Hematology 17. Postsurgical complications 18. Anesthesia 19. Hemostasis 20. Pharmacology.
1. Diabetic patients 2. Acute coronary syndrome (ACS) 3. Bleeding events 4. Short term risk 5. Long term risk 6. Coronary artery disease 7. Diabetes mellitus 8. Cardiovascular disease 9. Anticoagulation therapy 10. Antiplatelet therapy 11. Thrombosis 12. Hemorrhage 13. Ischemic heart disease 14. Myocardial infarction 15. Stroke 16. Renin-angiotensin-aldosterone system (RAAS) 17. Hyperglycemia 18. Coagulation cascade 19. Platelet function 20. Thrombocytopenia 21. Risk factors 22. Comorbidities 23. Mortality 24. Outcomes 25. Treatment options.
1. Discrimination 2. Initiator (IF-3) 3. Translation initiation factor 4. IF-3 5. Transcription elongation factor 6. Translation initiation 7. Protein synthesis 8. Initiation factors 9. Translation machinery 10. Ribosome binding 11. Translation start site 12. Initiation complex 13. Transcription elongation 14. Protein synthesis regulation 15. Translation initiation sites 16. Factor binding 17. Translation initiation step 18. Translation elongation factors 19. Protein synthesis initiation 20. Translation initiation process.
1. Downregulation 2. Scribble protein 3. Mislocalization 4. Cell transformation 5. Mammary tumorigenesis 6. Apico-basal polarity 7. Epithelial-mesenchymal transition (EMT) 8. Cancer development 9. Tumor suppression 10. Membrane localization 11. Cell signaling 12. Cellular processes 13. Epithelial cells 14. Oncology 15. Neoplasia 16. Apoptosis 17. Invasion 18. Metastasis 19. Cancer prevention 20. Biomarkers 21. Protein expression 22. Signaling pathways 23. Cellular structure 24. Cancer research 25. Apical junction complex (AJC) 26. Intracellular trafficking 27. Protein regulation 28. Cell cycle 29. Molecular biology 30. Cellular components.
1. Primary response 2. Early antibody response 3. Activated B cells 4. Migration 5. Inner paracortical areas 6. Outer paracortical areas 7. Oxysterols 8. Accumulation 9. Stromal cells 10. Paracortex 11. Immunological response 12. B cell activation 13. Chemotaxis 14. Cytokinesis 15. Signal transduction 16. Lipid metabolism 17. Oxidative stress 18. Immunology 19. Lymph nodes 20. Antigen presentation.
1. Enhanced early production 2. Inflammatory chemokines 3. Viral control 4. Lung 5. Immunity 6. Antiviral response 7. Chemokine production 8. Innate immunity 9. Viral replication 10. Cytokines 11. Inflammation 12. Lung inflammation 13. Viral load 14. Immunopathology 15. Respiratory system 16. Antiviral defense 17. Chemoattractants 18. Immunological response 19. Inflammatory mediators 20. Virus clearance.
1. Epidemiological disease burden 2. Noncommunicable diseases (NCDs) 3. Prevalence 4. Low economic settings 5. Developing countries 6. Income level 7. Health disparities 8. Chronic diseases 9. Cardiovascular diseases 10. Diabetes 11. Cancer 12. Respiratory diseases 13. Risk factors 14. Lifestyle diseases 15. Access to healthcare 16. Healthcare infrastructure 17. Healthcare resources 18. Socioeconomic status 19. Public health 20. Global health.
1. Epigenetic modulating agents 2. EMAS (Epigenetic Modulating Agents) 3. Antitumor immune response 4. Cancer model system 5. Epigenetics 6. Immunomodulation 7. Cancer 8. Tumor 9. Epigenetic regulators 10. DNA methylation 11. Histone modifications 12. Chromatin remodeling 13. Cancer treatment 14. Immunotherapy 15. Epigenetic therapy 16. Cancer immunology 17. Epigenetic drugs 18. Anticancer agents 19. Epigenetic markers 20. Immune response modulation.
1. Peripheral IV (intravenous) drug administration 2. Errors 3. Bolus administration 4. Multiple step medicine preparations 5. Intravenous therapy 6. Medication errors 7. Infusion errors 8. Bolus doses 9. Medication preparation 10. IV administration technique 11. IV site complications 12. IV medication delivery 13. IV infusion pumps 14. IV administration sets 15. IV medication vials 16. IV medication syringes 17. IV medication compatibility 18. IV medication errors 19. IV medication safety 20. IV medication administration training.
1. Ethanol 2. Stress 3. Bacteria 4. Ibp (Iron-Binding Protein) 5. Expression 6. Decreases 7. Transcription 8. Regulation 9. Gene expression 10. Alcohol tolerance 11. Adaptation 12. Response 13. Microbiology 14. Biochemistry 15. Proteins 16. Iron metabolism 17. Gene repression 18. Promoter activity 19. Regulatory genes 20. Environmental stressors.
1. Exposure to fine particulate air pollution 2. Air quality 3. Particulate matter 4. Anxiety 5. Prevalence 6. Mental health 7. Psychological effects 8. Public health 9. Environmental pollution 10. Epidemiology 11. Stress 12. Cardiovascular disease 13. Respiratory health 14. Epidemiological studies 15. Air pollution and anxiety 16. Mood disorders 17. Neuropsychology 18. Health outcomes 19. Urban environments 20. Population health.
1. Febrile seizures 2. Epilepsy 3. Threshold 4. Development 5. Seizures 6. Fever 7. Childhood 8. Brain 9. Neurology 10. Neurological disorders 11. Risk factors 12. Incidence 13. Prevalence 14. Recurrence 15. Prognosis 16. Long-term effects 17. Neurological assessment 18. Neurological examination 19. Brain imaging 20. Electroencephalogram (EEG) 21. Treatment 22. Prevention 23. Follow-up care 24. Pediatrics 25. Child health.
1. Febrile seizures 2. Epilepsy 3. Seizures 4. Fever 5. Threshold 6. Development 7. Neurology 8. Brain 9. Childhood 10. Brain damage 11. Risk factor 12. Recurrent seizures 13. Early onset epilepsy 14. Brain function 15. Neurological disorders 16. Temperature 17. Child health 18. Brain injury 19. Long-term effects 20. Neurological conditions.
1. Female carriers 2. Apolipoprotein E4 (ApoE4) 3. APOE4 allele 4. Increased risk 5. Dementia 6. Alzheimer's disease 7. Genetic risk factor 8. Neurodegenerative disorder 9. ApoE genotype 10. Cognitive decline 11. Elderly population 12. Neuroprotection 13. Brain health 14. Neuropsychological assessment 15. Neuroimaging studies 16. Risk reduction strategies 17. Prevention measures 18. Early diagnosis 19. Neurological conditions 20. Geriatric population.
1. Flexible molecules 2. Rigid molecules 3. Steric hindrance 4. Tumor microenvironment 5. Conformational change 6. Molecular mobility 7. Cancer cells 8. Obstacles 9. Interactions 10. Hindrance factors 11. Molecular dynamics 12. Constrained structures 13. Tumor tissue 14. Biomolecules 15. Chemical structures 16. Molecular shape 17. Restriction 18. Biochemical environment 19. Adaptability 20. Biological complexities.
1. Foxo3a (transcription factor) 2. Neuronal death 3. Reactive oxygen species (ROS) 4. Apoptosis (programmed cell death) 5. Oxidative stress 6. Mitochondria 7. Signal transduction 8. Redox regulation 9. Foxo3a activation 10. ROS production 11. Neuronal survival 12. Antioxidants 13. Neuroprotection 14. ROS scavenging 15. Mitochondrial dysfunction 16. Neurodegenerative diseases 17. NF-κB (nuclear factor kappa-B) 18. FOXO3a-ROS signaling 19. Cellular senescence 20. Autophagy (cellular self-digestion) 21. MAPK (mitogen-activated protein kinase) 22. JNK (c-Jun N-terminal kinase) 23. p38 MAPK 24. ERK (extracell
1. Free histones 2. Histone degradation 3. Rad53 4. DNA replication 5. Dependent mechanism 6. Histone modification 7. Nucleosome disassembly 8. Histone turnover 9. Chromatin remodeling 10. DNA damage response 11. Post-replication repair 12. Histone-binding proteins 13. Histone chaperones 14. Histone ubiquitination 15. Histone proteases 16. Histone deacetylases 17. Histone phosphorylation 18. Checkpoint control 19. Cell cycle regulation 20. Genetic instability.
1. Myelodysplastic Syndrome (MDS) 2. Genomic alterations 3. Functional consequences 4. Animal model 5. Lack of understanding 6. Myeloid diseases 7. Hematopoiesis 8. Genetics 9. Epigenetics 10. Chromosomal abnormalities 11. Single nucleotide polymorphisms 12. Copy number variations 13. Gene mutations 14. Protein dysfunction 15. Anemia 16. Neutropenia 17. Thrombocytopenia 18. Bone marrow failure 19. Hematopoietic stem cells 20. Translational research 21. Preclinical studies 22. Biomarkers 23. Clinical trials 24. Disease progression 25. Therapeutic interventions.
1. Zebrafish 2. Neuralation 3. Neuroectoderm cells 4. Anterior membrane 5. Fz (Frizzled) protein 6. PCP (Planar Cell Polarity) 7. Dependent 8. Localizes 9. Membrane 10. Neurodevelopment 11. Cell signaling 12. Planar cell polarity pathway 13. Neuroepithelial cells 14. Anterior-posterior axis 15. Cellular localization 16. Membrane proteins 17. Zebrafish neural development 18. Cellular polarization 19. Frizzled receptors 20. Planar cell polarity proteins.
1. Zebrafish 2. Neuralation 3. Notochord 4. Anterior membrane 5. Fz (Frizzled) 6. PCP (Planar Cell Polarity) 7. Dependent 8. Localizes 9. Cell membrane 10. Anterior 11. Notochord cells 12. Neural development 13. Planar cell polarity pathway 14. Membrane localization 15. Signal transduction 16. Cellular localization 17. Zebrafish neural tube 18. Cellular polarity 19. Anterior-posterior axis 20. Developmental biology.
1. GATA3 gene 2. Hematopoiesis 3. Hematopoietic stem cells (HSC) 4. Transcription factor 5. Gene expression 6. HSC function 7. Hematopoietic development 8. Blood cell differentiation 9. Stem cell self-renewal 10. Hematopoietic progenitor cells 11. Hematopoietic lineages 12. Hematopoietic regulation 13. Stem cell niche 14. Hematopoietic differentiation 15. Hematopoietic homeostasis 16. Hematopoietic regulation genes 17. Hematopoietic developmental biology 18. Stem cell biology 19. Hematopoietic gene expression 20. Hematopoietic signaling pathways.
1. Gene expression 2. Genetically identical cells 3. Homozygous cells 4. Clonal cells 5. Consistent gene expression 6. Stable gene expression 7. Intra-cellular variation 8. Genetic determinism 9. Epigenetic modifications 10. Transcriptional regulation 11. Developmental stages 12. Environmental influences 13. Cellular differentiation 14. Gene silencing 15. Gene activation 16. Gene regulation 17. Cellular homeostasis 18. Monoclonal culture 19. Cell line stability 20. Gene expression profiling 21. Gene expression analysis 22. Genetic uniformity 23. Cellular identity 24. Cellular consistency 25. Cellular stability.
1. Glycolysis 2. Primary metabolic pathway 3. Glycometabolic pathways 4. Cellular metabolism 5. Energy production 6. Glucose metabolism 7. Embden-Meyerhoff pathway 8. Anaerobic metabolism 9. Glycolytic enzymes 10. Glycolytic pathway 11. Cellular energy 12. Metabolic pathways 13. Carbohydrate metabolism 14. Glucose catabolism 15. ATP production 16. Cellular respiration 17. Biochemical pathway 18. Cellular energy production 19. Metabolic processes 20. Glycolytic intermediates.
1. Golli deficiency 2. T cells 3. Anergic phenotype 4. Adaptive immune response 5. Ca2+ (Calcium ion) 6. Cytosol 7. T cell differentiation 8. Immunological tolerance 9. Calcium signaling 10. Apoptosis (Programmed cell death) 11. Immunosuppression 12. Calcium homeostasis 13. T cell activation 14. Regulatory T cells (Tregs) 15. Calcium channels 16. Calcium pumps 17. Immunological synapse 18. Calcium-dependent signaling pathways 19. Immunological tolerance mechanisms 20. Calcium-sensing proteins.
1. HNF4A mutations 2. Diabetes 3. Mutant carriers 4. HNF4A gene 5. Genetic mutations 6. Juvenile diabetes 7. Type 2 diabetes 8. Hepatocyte nuclear factor 4 alpha 9. Diabetes onset 10. Childhood diabetes 11. HNF4A-related diabetes 12. HNF4A gene variants 13. Diabetes risk 14. HNF4A gene mutation 15. HNF4A protein function 16. Diabetes causation 17. HNF4A-mediated diabetes 18. HNF4A-linked diabetes 19. Diabetes susceptibility 20. HNF4A-associated diabetes.
1. Headaches 2. Cognitive impairment 3. Correlation 4. Neurology 5. Brain function 6. Mental performance 7. Cognitive abilities 8. Healthy brain 9. Absence of correlation 10. Medical research 11. Neurological disorders 12. Cognitive assessment 13. Brain imaging 14. Cognitive tests 15. Clinical studies 16. Neurological assessment 17. Cognitive decline 18. Headache types 19. Cognitive development 20. Healthy aging 21. Neurological conditions 22. Brain health 23. Cognitive disorders 24. Research findings 25. Epidemiology.
1. Healthcare delivery efficiency 2. Crowded delivery centers 3. Structural elements 4. Logistical improvements 5. Interpersonal elements 6. Healthcare facility design 7. Workflow optimization 8. Patient flow management 9. Staff communication 10. Equipment management 11. Supply chain management 12. Patient experience 13. Patient safety 14. Waiting times 15. Patient throughput 16. Healthcare operations 17. Healthcare productivity 18. Healthcare capacity 19. Healthcare accessibility 20. Healthcare quality.
1. Helminths 2. Immune system 3. Macrophages 4. IL-4 5. Mycobacterium tuberculosis 6. Replication 7. Parasitic infection 8. Immunomodulation 9. Pro-inflammatory cytokines 10. Th2 response 11. T helper cells 12. Regulatory T cells (Tregs) 13. Immune suppression 14. Inflammatory response 15. Immunopathology 16. Innate immunity 17. Adaptive immunity 18. Antigen presentation 19. Cytokine production 20. Toll-like receptors (TLRs) 21. NF-kB signaling 22. MHC class II 23. Apoptosis 24. Granulomas 25. Tuberculosis 26. Co-infection 27. Immunosuppression markers 28. Transcription factors 29. Epigenetics 30. Immunological tolerance
1. Hematopoietic stem cells 2. Stem cell purification 3. Purity rate 4. Hematopoietic stem cell isolation 5. Cell sorting 6. Immunoselection 7. Fluorescence-activated cell sorting (FACS) 8. Magnetic-activated cell sorting (MACS) 9. Hematopoietic progenitor cells 10. CD34 selection 11. CD34+ cells 12. Hematopoietic colony-forming cells 13. Flow cytometry 14. Cell enrichment 15. Cell expansion 16. Cell culture 17. Hematopoietic stem cell transplantation 18. Bone marrow transplant 19. Peripheral blood stem cells 20. Up to 50% purity.
1. Cardiopulmonary Fitness 2. Mortality Rate 3. High Fitness Level 4. All-Cause Mortality 5. Sudden Cardiac Death 6. Life Expectancy 7. Fitness-Mortality Paradox 8. Aerobic Capacity 9. VO2max 10. Mortality Risk 11. Survival Rate 12. Healthy Aging 13. Morbidity 14. Mortality Hazard 15. Physical Fitness 16. Mortality Benefit 17. Mortality Disparities 18. Long-Term Survival 19. Cardiovascular Disease 20. Mortality Curve.
1. High dietary calcium intakes 2. Unnecessary 3. Prevention 4. Secondary hyperparathyroidism 5. Subjects 6. 25 oh D levels 7. Above 75 nmol liter 8. Vitamin D 9. Calcium homeostasis 10. Parathyroid hormone 11. Bone health 12. Calcium metabolism 13. Nutritional requirements 14. Vitamin D deficiency 15. Hyperparathyroidism prevention strategies.
1. CRP (C-Reactive Protein) 2. High levels of CRP 3. Chronic Obstructive Pulmonary Disease (COPD) 4. COPD exacerbations 5. Risk reduction 6. Inflammation marker 7. Biomarker 8. Chronic respiratory disease 9. Lung disease 10. Respiratory health 11. C-reactive protein and COPD 12. COPD management 13. COPD prognosis 14. CRP-based diagnosis 15. CRP-based treatment 16. CRP levels and COPD severity 17. CRP and COPD inflammation 18. CRP and COPD exacerbations prevention.
1. Copeptin 2. Diabetes 3. Risk reduction 4. High levels 5. Blood glucose 6. Biomarker 7. Prediabetes 8. Insulin resistance 9. Type 2 diabetes 10. Cardiovascular disease 11. Inflammation 12. Vasopressin 13. Blood tests 14. Endocrine system 15. Metabolic syndrome 16. Glucose metabolism 17. Prognosis 18. Prevention 19. Health outcomes 20. Epidemiology.
1. High sensitivity cardiac troponin T (hs-cTnT) 2. Dosage 3. Diagnostic accuracy 4. Acute myocardial injury (AMI) 5. Symptom onset 6. Time frame (less than 3 hours) 7. Myocardial injury 8. Cardiac markers 9. Troponin levels 10. Diagnosis limitations 11. Acute coronary syndrome 12. Myocardial infarction 13. Cardiac damage 14. Threshold values 15. False negatives 16. Early presentation 17. Clinical assessment 18. Electrocardiogram (ECG) 19. Chest pain 20. Ruling out AMI.
1. Histone demethylase 2. Transient decrease 3. Histone methylation 4. Nuclear receptors 5. Ligand-dependent induction 6. Transcription 7. Recruitment 8. Epigenetic modifications 9. Chromatin remodeling 10. Histone tails 11. Demethylation 12. Transcription factors 13. Epigenetics 14. Coactivators 15. Chromatin accessibility 16. Gene expression 17. Epigenetic regulation 18. Histone modifications 19. Ligand binding 20. Transcriptional activation.
1. Homozygous deletion 2. Murine sbds gene 3. Osterix expressing mesenchymal stem and progenitor cells (MPCs) 4. Prevents oxidative stress 5. Murine sbds gene deletion 6. Osterix-MPCs 7. Homozygous mutation 8. sbds gene function 9. Mice model 10. Oxidative stress prevention 11. MSCs (Mesenchymal Stem Cells) 12. Progenitor cells 13. Gene deletion 14. Antioxidant effects 15. Mice mesenchymal stem cells 16. sbds gene role 17. Oxidative damage 18. Gene expression 19. Mice model of oxidative stress 20. Stem cell research.
1. Human T-lymphotropic virus type 1 (HTLV-1) 2. Myelopathy 3. Tropical spastic paraparesis (TSP) 4. Hamartomatous TSP (HAM-TSP) 5. HTLV-1 associated myelopathy (HAM) 6. Immunoglobulin G (IgG) 7. Antibodies 8. Cross-reactivity 9. Tax protein 10. Immunodominant epitope 11. HTLV-1 patients 12. IgG production 13. Neurodegenerative disease 14. Tropical diseases 15. Spastic paraparesis 16. HTLV-1 infection 17. Tax protein antibodies 18. Neurological disorders 19. HTLV-1 related disorders.
1. Hyperfibrinogenemia 2. Fibrinogen levels 3. Thrombosis 4. Femoropopliteal bypass 5. Surgical intervention 6. Anticoagulation 7. Rates of thrombosis 8. Blood clots 9. Coagulation factors 10. Risk reduction 11. Prevention strategies 12. Thromboprophylaxis 13. Bypass grafts 14. Perioperative management 15. Vascular surgery 16. Hemostasis 17. Hematology 18. Cardiovascular diseases.
1. Hyperfibrinogenemia 2. Thrombosis 3. Femoropopliteal bypass 4. Surgical intervention 5. Blood clotting 6. Fibrinogen levels 7. Coagulation 8. Risk factors 9. Vascular surgery 10. Thrombotic events 11. Post-operative complications 12. Hemostasis 13. Prothrombotic conditions 14. Blood flow obstruction 15. Venous thrombosis 16. Arterial thrombosis 17. Anticoagulation therapy 18. Thromboprophylaxis 19. Cardiovascular disease 20. Peri-operative management.
1. Hypertension 2. Type 1 Diabetes 3. Diabetes Complications 4. Blood Pressure 5. Diabetes and Hypertension 6. Type 1 Diabetes Patients 7. Cardiovascular Disease 8. Diabetes Management 9. Risk Factors 10. Hypertension Prevalence 11. Diabetes-Related Hypertension 12. Diabetes Comorbidities 13. Cardiovascular Risks 14. Diabetes Care 15. Hypertension Treatment 16. Diabetes-Induced Hypertension 17. Diabetes Research 18. Elevated Blood Pressure 19. Diabetes Consequences 20. Diabetes Screening.
1. Hypocretin neurons 2. Panic state 3. Rats 4. Neurons and panic attacks 5. Hypocretin and anxiety 6. Animal model 7. Neurotransmitter 8. Hypocretin receptors 9. Behavioral response 10. Stress response 11. Neurophysiology 12. Neurochemistry 13. Panic disorder 14. Hypothalamus 15. Arousal 16. Brain function 17. Behavioral tests 18. Neuroanatomy 19. Hypocretin signaling 20. Emotional response.
1. Hypoglycemia 2. Dementia 3. Risk factor 4. Blood sugar levels 5. Brain health 6. Cognitive function 7. Elderly population 8. Diabetes mellitus 9. Insulin therapy 10. Neurological conditions 11. Brain diseases 12. Memory loss 13. Mental decline 14. Neurodegenerative disorders 15. Long-term complications 16. Hypoglycemic episodes 17. Brain damage 18. Neurological impairment 19. Chronic hypoglycemia 20. Cerebral dysfunction.
1. Hypothalamus 2. Glutamate 3. Neurotransmission 4. Energy balance 5. Homeostasis 6. Appetite regulation 7. Metabolism 8. Synaptic transmission 9. Excitatory neurotransmitter 10. Neuroendocrine system 11. Feeding behavior 12. Obesity 13. Neuroplasticity 14. Receptors (mGluRs, NMDA) 15. Neuroadaptation 16. Signal transduction 17. Neurotransmitter release 18. Glutamate reuptake 19. Energy homeostasis 20. Neuroimaging 21. Neuropharmacology 22. Brain circuits 23. Leptin 24. Ghrelin 25. Food intake 26. Satiety 27. Body weight regulation.
1. IFIT1 protein 2. Viral replication 3. Sequestration 4. Mis-capped viral RNAs 5. RNA binding protein 6. Virus infection 7. Antiviral response 8. RNA cap 9. RNA modification 10. RNA recognition 11. Post-transcriptional regulation 12. Viral RNA metabolism 13. RNA surveillance 14. Innate immunity 15. Antiviral defense 16. RNA-protein interaction 17. mRNA translation 18. RNA stability 19. RNA processing 20. Viral RNA synthesis.
1. IRG1 protein 2. Antiviral effects 3. Neurotropic viruses 4. Proteins, viral, inhibition 5. IRG1 and neurotropic viruses 6. Viral infections, nervous system 7. IRG1, antiviral activity 8. Neurovirology 9. IRG1 expression 10. IRG1 function 11. Neurotropic virus replication 12. IRG1 mechanism of action 13. Antiviral therapy 14. IRG1 role in neuroprotection 15. IRG1 and viral neuroinvasion 16. IRG1 and viral pathogenesis 17. IRG1 and virus-induced neurodegeneration 18. IRG1 and viral neurotoxicity.
1. ITAM (Immune Receptor Tyrosine-Based Activation Motif) 2. Phosphorylation 3. T cell receptor (TCR) 4. ECD (Extracellular Domain) 5. Cytoplasmic Tail 6. Signal Transduction 7. TCR Signaling 8. Tyrosine Kinase 9. Inhibition 10. Immunology 11. T cell Activation 12. ITAM Phosphorylation Site 13. TCR Proximal Signaling 14. Lipid Binding 15. Phosphoinositides 16. Signal Propagation 17. Immunological Synapse 18. TCR Clustering 19. Co-stimulation 20. Immunological Signaling.
1. Iga plasma cells 2. Transglutaminase 2 (tTG-2) 3. Duodenal mucosa 4. Gluten-free diet 5. Commencement 6. Accumulation 7. Celiac disease 8. Autoimmune response 9. Intestinal mucosa 10. Immunoglobulin A (IgA) 11. Antibodies 12. Small intestine 13. Gluten intolerance 14. Tissue transglutaminase 15. Inflammation 16. Intestinal damage 17. Gastrointestinal tract 18. Food intolerance 19. Immunohistochemistry 20. Diagnosis 21. Biopsy 22. Immunology 23. Enteropathy.
1. Immune complexes 2. Triggered cell death 3. Apoptosis (programmed cell death) 4. Necrosis (unprogrammed cell death) 5. Extracellular release 6. Neutrophils 7. High-mobility group box 1 protein (HMGB1) 8. Inflammation 9. Immunity 10. Autoimmunity 11. Complement system 12. Antibodies 13. Cytokines 14. Reactive oxygen species (ROS) 15. Pyroptosis (inflammasome-mediated cell death) 16. Necroinflammation 17. Damage-associated molecular patterns (DAMPs) 18. Toll-like receptors (TLRs) 19. Innate immunity 20. Extracellular matrix.
1. Immune responses 2. Inflammatory Th17 cells 3. Anti-inflammatory iTregs 4. T helper 17 cells (Th17) 5. Regulatory T cells (iTregs or Tregs) 6. Immunity 7. Inflammation 8. Cellular response 9. Adaptive immune system 10. Cytokines 11. Th17 cell differentiation 12. Treg cell development 13. Immunoregulation 14. Autoimmunity 15. Pro-inflammatory 16. Anti-inflammatory 17. Immune balance 18. Immunopathology 19. Inflammatory response 20. Immunosuppression.
1. Adult tissue 2. T cells 3. Memory T cells 4. Immunity 5. Adaptive immune system 6. Antigen exposure 7. Antigen memory 8. Activated T cells 9. Long-term immunity 10. Proliferation 11. Differentiation 12. Homeostasis 13. Survival 14. Recirculation 15. Antigen recognition 16. CD4+ T cells 17. CD8+ T cells 18. Clonal expansion 19. Effector T cells 20. Receptor repertoire 21. Antibody-dependent cellular cytotoxicity (ADCC) 22. Helper T cells 23. Cytotoxic T cells 24. Immunological memory 25. Secondary response.
1. Saccharomyces cerevisiae 2. Domesticated populations 3. Whole chromosome aneuploidy 4. Rare 5. Uncommon 6. Chromosomes 7. Aneuploidy 8. Genetic variation 9. Yeast population genetics 10. Chromosome number variation 11. Genome stability 12. Saccharomyces cerevisiae genetics 13. Chromosome imbalance 14. Genetic disorders 15. Whole genome analysis 16. Chromosomal aberrations 17. Genetic diversity 18. Domesticated strains 19. Chromosome gains or losses 20. Genetic selection against aneuploidy.
1. Mice 2. P. Chabaudi parasites 3. Proliferation rate 4. Early infection 5. Inoculation 6. Parasite numbers 7. Infection dose 8. Immunity response 9. Host-parasite interaction 10. Replication 11. Infection dynamics 12. Infection load 13. Parasite burden 14. Host defense 15. Pathogenesis 16. Immunological response 17. Infectious dose response 18. Parasite growth 19. Host susceptibility 20. Infection outcome.
1. Mouse models 2. CSF1R (Colony-stimulating factor 1 receptor) 3. Loss of CSF1R 4. Moz (Maf Binding Protein 2, also known as MafB) 5. TIF2 (Transcription Intermediary Factor 2, also known as NF-E2) 6. Leukemogenesis (Development of leukemia) 7. Induced leukemia 8. Mouse leukemia 9. Colony-stimulating factor 1 10. MafB 11. NF-E2 12. Transcription factor 13. Leukemia development 14. Mouse genetics 15. Hematopoiesis (Formation of blood cells) 16. Mouse hematopoiesis 17. CSF1 signaling 18. Leukemia mouse model 19. Hematopoietic stem cells 20. Myeloid leukemia.
1. Transgenic mice 2. Green fluorescent protein (GFP) 3. Sox2 promoter 4. Cell proliferation markers 5. Colocalization 6. Immunostaining 7. Confocal microscopy 8. Cell differentiation 9. Stem cells 10. Neural development 11. Gene expression 12. Epigenetics 13. Cell cycle 14. Proliferating cells 15. Apoptosis 16. Gene regulation 17. Developmental biology 18. Neuroscience 19. Molecular biology 20. Biochemistry.
1. ADHD medications 2. Young adults 3. Middle-aged adults 4. Cardiovascular events 5. Risk 6. Serious 7. Current use 8. Remote use 9. Safety 10. Side effects 11. Heart health 12. Stroke 13. Myocardial infarction 14. Hypertension 15. Arrhythmia 16. Long-term use 17. Short-term use 18. Epidemiology 19. Clinical trials 20. Pharmacology 21. Safety studies 22. Health outcomes 23. Methylphenidate 24. Lisdexamfetamine 25. Atomoxetine 26. Dextroamphetamine 27. Cardiovascular safety 28. Neurostimulants 29. Adult population 30. Healthcare 31. Treatment 32. Psychostimulants 33. Risk assessment 34. Long-term cardiovascular effects 35. Clinical research 36
1. Heart failure 2. Incidence 3. Decrease 4. Women 5. since 1979 6. Cardiac diseases 7. Trends 8. Health statistics 9. Mortality rate 10. Risk factors 11. Prevalence 12. Epidemiology 13. Cardiovascular health 14. Medical research 15. Public health 16. Demographic trends 17. Health interventions 18. Prevention strategies 19. Lifestyle factors 20. Population studies.
1. Cervical cancer 2. Incidence rates 3. Decrease 4. Prevalence 5. Cancer statistics 6. Cervical neoplasms 7. Mortality rate 8. Screening programs 9. Pap smear 10. HPV (Human Papillomavirus) 11. Vaccination 12. Prevention 13. Risk factors 14. Early detection 15. Public health 16. Cancer trends 17. Health policy 18. Cancer prevention strategies 19. Cervical cancer screening guidelines 20. Cancer research.
1. Incidence rates 2. Cervical cancer 3. Screening programs 4. Nationwide 5. Uterine cervical cancer 6. Cytology 7. Detect 8. Prevention 9. Cancer screening 10. Public health 11. Cancer incidence 12. Cancer screening methods 13. Cervical cancer screening 14. Cancer diagnosis 15. Health policy 16. Cancer trends 17. Cancer prevention strategies 18. Cancer mortality 19. Screening effectiveness 20. Cancer risk factors.
1. Microtubule acetylation 2. Increased microtubule acetylation 3. LRRK2 (Leucine-Rich Repeat Kinase 2) 4. Roc (Ras of Complex A) domain 5. Mutation 6. Locomotor deficits 7. Repair 8. Neurodegenerative disease 9. Parkinson's disease 10. Protein kinase 11. Post-translational modification 12. Acetylation 13. Molecular mechanism 14. Cellular response 15. Lysine acetyltransferase 16. Lysine acetylation 17. Neuroprotection 18. Phosphorylation 19. Signal transduction 20. Therapeutic intervention.
1. Vessel density 2. Chemotherapy treatments 3. Reduction in fibrosis 4. Efficacy 5. Anticancer drugs 6. Angiogenesis 7. Tumor microenvironment 8. Neovascularization 9. Cancer progression 10. Drug resistance 11. Tumor vasculature 12. Therapeutic response 13. Tumor growth 14. Anti-angiogenic agents 15. Hypoxia 16. Tumor metabolism 17. Tumor microvessels 18. Cancer therapy 19. Treatment outcome 20. Tumor vasculature density.
1. Individuals 2. Low serum vitamin D concentrations 3. Multiple sclerosis 4. Risk 5. Vitamin D deficiency 6. Serum vitamin D levels 7. Multiple sclerosis risk 8. Epidemiology 9. Neurology 10. Immunology 11. Disease progression 12. Symptoms 13. Prevalence 14. Vitamin D supplementation 15. Vitamin D and MS 16. Vitamin D insufficiency 17. Vitamin D and neuroprotection 18. Vitamin D and inflammation 19. Vitamin D and demyelination 20. Vitamin D and MS prognosis.
1. Human T-cell lymphotropic virus type 1 (HTLV-1) 2. Infection 3. African origin 4. Prevalence 5. Demographics 6. Epidemiology 7. HIV co-infection 8. Risk factors 9. Transmission 10. Symptoms 11. Diagnosis 12. Treatment 13. Endemic areas 14. Africa 15. Population 16. Disease burden 16. Health disparities 17. Immunology 18. Public health 19. Research 20. Prevention.
1. Inositol lipid 3-phosphatase 2. PTEN (Phosphatase and tensin homolog) 3. Phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) 4. Phosphatidylinositol 4-phosphate (PtdIns(4)P) 5. Lipid phosphatase 6. PTEN catalytic activity 7. Phosphatidylinositol signaling 8. Phosphatidylinositol phosphates 9. Inositol phosphates 10. Cell signaling 11. Lipid metabolism 12. PTEN function 13. Phosphatidylinositol 3-phosphate (PtdIns(3)P) 14. Phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) 15. Phosphatidylinositol signaling pathway 16. Lipid signaling 17. PTEN regulation
1. Mental health professionals 2. Physical health care professionals 3. Homelessness prevention 4. Intervention programs 5. Collaborative care 6. Housing first model 7. Health care access 8. Mental health treatment 9. Primary care 10. Social support 11. Health and housing 12. Case management 13. Substance abuse treatment 14. Chronic illness management 15. Community resources 16. Health care utilization 17. Evidence-based practices 18. Health outcomes 19. Mental health stabilization 20. Public health.
1. Insomnia 2. Cognitive Behavioral Therapy (CBT) 3. Sleep disorders 4. Treatment 5. Cognitive techniques 6. Behavioral techniques 7. Sleep hygiene 8. Sleep patterns 9. Sleep onset 10. Sleep maintenance 11. Anxiety 12. Stress 13. Relaxation techniques 14. Sleep education 15. Sleep behavior 16. Sleep beliefs 17. Sleep perception 18. Sleep scheduling 19. Sleep restriction therapy 20. Stimulus control therapy.
1. Insulin 2. Kidney failure 3. Severe kidney disease 4. Diabetic nephropathy 5. Renal function 6. Diabetes complications 7. End-stage renal disease 8. Insulin therapy 9. Diabetic kidney damage 10. Nephropathy risk 11. Insulin side effects 12. Diabetic nephrosis 13. Insulin dosage 14. Kidney injury 15. Insulin treatment and kidney damage 16. Diabetic nephropathy symptoms 17. Insulin-induced kidney damage 18. Renal insufficiency 19. Insulin and kidney health 20. Diabetic kidney disease.
1. Classroom-based collaborative learning 2. Web-based collaborative learning 3. Integration 4. Subpar class performance 5. Classroom instruction 6. Online learning 7. Group work 8. Technology integration 9. Student engagement 10. Learning outcomes 11. Classroom technology 12. Collaborative education 13. E-learning 14. Synchronous learning 15. Asynchronous learning 16. Pedagogy 17. Instructional design 18. Digital tools 19. Student interaction 20. Learning environment.
1. Ivermectin 2. Lymphatic filariasis 3. Antifilarial drug 4. Parasitic infection 5. Microfilariae 6. Worm infestation 7. Mass drug administration 8. Neglected tropical disease 9. Preventive chemotherapy 10. Endemic areas 11. Transmission reduction 12. Disease control 13. Annual mass treatment 14. River blindness 15. Onchocerciasis co-endemicy 16. Albendazole 17. Diethylcarbamazine citrate 18. Mectizan 19. Elimination program 20. Public health.
1. Ivermectin 2. Onchocerciasis 3. Parasitic infection 4. Neglected tropical disease 5. River blindness 6. Antiparasitic drug 7. Mectizan 8. Onchocerca volvulus 9. Microfilaria 10. Subcutaneous administration 11. Mass drug administration 12. Elimination of onchocerciasis 13. Transmission control 14. Prevention of blindness 15. Community-directed treatment 16. Public health 17. Tropical medicine 18. Endemic areas 19. Infectious disease 20. Eyesight preservation.
1. LDL Cholesterol  2. Cardiovascular Disease  3. Involvement  4. Development  5. No effect  6. Myth  7. Misconception  8. Controversial  9. Debate  10. Lipoproteins  11. Atherosclerosis  12. Plaque  13. Coronary artery disease  14. Heart attack  15. Stroke  16. Risk factors  17. Cholesterol transport  18. Lipid profile  19. HDL cholesterol  20. Triglycerides.
1. Bacillus subtilis 2. Sporulation 3. Efficiency 4. ClpC protein 5. Lack 6. Affect 7. Proteolysis 8. Chaperone 9. Heat shock response 10. Cell division 11. Endospore formation 12. Survival 13. Stress response 14. Protein degradation 15. Clp protease complex 16. Regulation 17. Gene expression 18. Development 19. Prokaryotic cells 20. Microbiology 21. Biochemistry.
1. Gabonese children 2. Schimmelpenning-Feuerstein-Mims Syndrome (SFM) 3. Less than 10 children 4. Plasma lactate 5. More than 5mmol/L 6. Schimmelpenning-Feuerstein-Mims Syndrome diagnosis 7. Gabonese population 8. Plasma lactate levels 9. Pediatric health 10. Rare diseases 11. Metabolic disorders 12. Neurological conditions 13. Medical research 14. Health statistics 15. Elevated lactate levels 16. Gabonese children's health 17. Schimmelpenning-Feuerstein-Mims Syndrome symptoms 18. Medical case studies.
1. Leukemia 2. Rho guanine nucleotide exchange factor (RhoGEF) 3. RhoA 4. Src activation 5. Represses 6. Rho signaling 7. Leukemia-associated RhoGEF 8. Inhibition 9. Guanine nucleotide exchange 10. Cell signaling 11. Src kinase 12. Rho protein family 13. Activation pathway 14. Cancer research 15. Cell cycle regulation 16. Cell motility 17. Apoptosis (programmed cell death) 18. Tumor suppressor 19. Oncology 20. Signal transduction.
1. Leukocytes 2. White blood cells 3. Red blood cell transfusion 4. Infectious complications 5. Blood transfusion-related infections 6. Neutrophils 7. Granulocytes 8. Leukopenia 9. Leukoemia 10. Leukocyte filtration 11. Leukodepletion 12. Transfusion-transmitted infections 13. Endotoxins 14. Sepsis 15. Fever 16. Chills 17. Bacterial contamination 18. Leukocyte count 19. Leukocyte reduction 20. Leukocyte removal 21. Transfusion reaction 22. Complement activation 23. Cytokine release 24. Leukocyte-platelet aggregation 25. Leukocyte-endothelial interaction.
1. Leukoreduction 2. Reduced leukocytes 3. Red blood cell transfusion 4. Infectious complications 5. Leukocyte reduction filter 6. White blood cells 7. Transfusion-transmitted infections 8. Neutropenia 9. Fever 10. Bacterial contamination 11. Leukocyte filtration 12. HLA antibodies 13. Transfusion reaction 14. Leukodepletion 15. Immunocompromised patients 16. Red cell storage 17. Leukocyte contamination 18. Transfusion safety 19. Leukocyte removal 20. Leukocyte reduction techniques.
1. Localization 2. Pin1 protein 3. Arabidopsis embryo 4. VPS9A protein (omit for keyword list) 5. Protein localization 6. Embryonic development 7. Arabidopsis thaliana 8. Cellular localization 9. Protein trafficking 10. Endomembrane system 11. Protein transport 12. Subcellular localization 13. Pin1 function 14. Embryogenesis 15. Plant development 16. Protein interaction 17. Membrane trafficking 18. Endosomal system 19. Cell signaling 20. Protein targeting.
1. Localization (of Pin1) 2. Arabidopsis (Thaliana) 3. Pin1 (protein) 4. Roots 5. VPS9A (protein) 6. Transport (protein) 7. Membrane (protein localization) 8. Endocytosis 9. Trafficking 10. Intracellular (transport) 11. Cellular localization 12. Protein localization 13. Arabidopsis thaliana roots 14. Pin1 protein localization 15. VPS9A independent 16. Endomembrane system 17. Cell biology 18. Plant biology 19. Protein function 20. Subcellular localization.
1. Low expression Mir7a 2. Mir7a repression 3. Target genes 4. Ovaries 5. Gene expression 6. Biological function 7. Repression of target genes 8. Mir7a function 9. Ovarian biology 10. Gene regulation 11. MicroRNA 12. Post-transcriptional regulation 13. RNA interference 14. mRNA expression 15. Gene silencing 16. Ovarian physiology 17. Small non-coding RNA 18. Target gene identification 19. Mir7a-target interactions 20. Ovarian disease or disorder 21. Gene expression profiling.
1. Mir7a 2. Low expression 3. Testis 4. Biological function 5. Gene expression 6. Testicular development 7. Spermatogenesis 8. Fertility 9. RNA interference 10. miRNAs (microRNAs) 11. Epigenetics 12. Gene regulation 13. Testicular gene expression 14. Mammalian testis 15. Reproductive system 16. Gene silencing 17. mRNA translation 18. Post-transcriptional regulation 19. Testicular gene regulation 20. Mirna expression.
1. Low nucleosome occupancy 2. Nucleosome occupancy 3. Low methylation levels 4. DNA methylation 5. Epigenetics 6. Chromatin structure 7. Transcriptional regulation 8. Histone modification 9. Cross-species correlation 10. Epigenomic landscape 11. Gene expression 12. Epigenetic marks 13. Genomic regions 14. Transcriptionally active regions 15. Open chromatin 16. Epigenetic inheritance 17. Epigenetic regulation 18. CpG methylation 19. Epigenetic modifications 20. Genomic imprinting.
1. Lupus prone mice 2. Curliproducing bacteria 3. Autoantibodies 4. Titers 5. Infection 6. Immunology 7. Mouse model 8. Autoimmune disease 9. Bacteria 10. Lupus-like symptoms 11. Antibody response 12. Inflammation 13. Immunoglobulins 14. Serology 15. Mouse strains 16. Experimental infection 17. Autoimmune response 18. Immunopathology 19. Lupus susceptibility 20. Lupus-associated bacteria.
1. Ly49Q protein 2. Neutrophil migration 3. Inflammation sites 4. Membrane rafts 5. Organization 6. Regulation 7. Neutrophil function 8. Immunity 9. Inflammatory response 10. Cell signaling 11. Membrane domains 12. Lipid rafts 13. Protein-lipid interactions 14. Membrane traffic 15. Cell adhesion 16. Cytoskeleton 17. Chemotaxis 18. Inflammatory mediators 19. Receptor clustering 20. Membrane fluidity.
1. Ly6c hi monocytes 2. Ly6c lo monocytes 3. Inflammatory capacity 4. Monocytes 5. Immunology 6. Inflammation 7. Cytokines 8. M1 macrophages 9. M2 macrophages 10. Pro-inflammatory 11. Anti-inflammatory 12. Immune response 13. CD11b 14. CD11c 15. Surface markers 16. Monocyte subsets 17. Inflammatory diseases 18. Immunotherapy 19. Cytokine production 20. Inflammatory mediators.
1. Ly6c hi monocytes 2. Ly6c lo monocytes 3. Inflammatory capacity 4. Monocytes 5. Immunology 6. Inflammation 7. Cytokines 8. Chemotaxis 9. Activation 10. Toll-like receptors 11. Pro-inflammatory 12. Anti-inflammatory 13. Macrophages 14. Mononuclear phagocytes 15. Surface markers 16. Immune response 17. Transcription factors 18. Gene expression 19. Inflammatory mediators 20. Immunophenotyping.
1. Lymphadenopathy 2. Knockin mouse 3. SHP-2 4. Mapk pathway 5. Absence of SHP-2 6. Lymph nodes 7. Inflammation 8. Immunodeficiency 9. Signal transduction 10. Map kinase 11. Genetic modification 12. Mouse model 13. Immunology 14. Lymph node enlargement 15. SHP-2 deficiency 16. Map kinase pathway disruption 17. Inflammatory response 18. SHP-2 knockout 19. Immunosuppression 20. MAPK signaling.
1. Macrolides 2. Myocardial Infarction 3. Protective effect 4. Cardiovascular disease 5. Heart attack 6. Antibiotics 7. Pharmacology 8. Cardiotoxicity 9. Clinical trials 10. Myocardium 11. Heart damage 12. Cardiovascular risk 13. Epidemiology 14. Contraindications 15. Drug interactions 16. Myocardial ischemia 17. Prevention 18. Side effects 19. Cardiac function 20. Heart health.
1. Macrolides 2. Antibiotics 3. Myocardial infarction (MI) 4. Cardiovascular protection 5. Cardiovascular disease (CVD) 6. Ischemic heart disease 7. Atherosclerosis 8. Inflammation 9. Plaque rupture 10. Thrombosis 11. Endothelial dysfunction 12. Anti-inflammatory effects 13. Antiplatelet effects 14. Cardioprotective effects 15. Risk reduction 16. Clinical trials 17. Epidemiology 18. Pharmacology 19. Mechanisms of action 20. Myocardial damage 21. Cardiac arrhythmias 22. Heart attack 23. Stroke 24. Secondary prevention.
1. Macropinocytosis 2. Protein uptake 3. Intracellular transport 4. Amino acids 5. Cell nutrition 6. Endocytosis 7. Protein digestion 8. Membrane ruffling 9. Vesicle trafficking 10. Intracellular digestion 11. Lysosomes 12. Nutrient acquisition 13. Endosomes 14. Membrane invagination 15. Protein catabolism 16. Receptor-mediated endocytosis 17. Cytoplasm 18. Protein degradation 19. Intracellular fluid 20. Nutrient absorption.
1. Post-translational modification 2. Proteins 3. Human cells 4. Lysine residues 5. Acetylation 6. Modification reaction 7. Protein function 8. Epigenetic marks 9. Enzymes (acetyltransferases) 10. Cofactors (acetyl-CoA) 11. Acetylation sites 12. Acetyl groups 13. Histone proteins 14. Transcription regulation 15. Metabolic processes 16. Cell signaling 17. Subcellular localization 18. Protein stability 19. Protein-protein interactions 20. Acetylation cycle.
1. Artemisinin-based combination therapy (ACT) 2. Malaria transmission 3. Mathematical models 4. Predictive analysis 5. Dramatic impact 6. Gametocytocidal drugs 7. Nongametocytocidal drugs 8. Malaria reduction 9. Public health 10. Epidemiology 11. Disease control 12. Antimalarial drugs 13. Parasite transmission 14. Mathematical simulation 15. Malaria eradication 16. Modeling and simulation 17. Disease dynamics 18. Healthcare intervention 19. Malaria treatment 20. Efficacy analysis.
1. Mercaptopurine 2. Thiopurine 3. Thiopurine methyltransferase (TPMT) 4. Anabolic process 5. Inactive form 6. Methylmercaptopurine 7. Thiopurine metabolism 8. Pharmacokinetics 9. Drug metabolism enzymes 10. Thiopurine S-methyltransferase (TPMT) variant 11. Pharmacogenetics 12. Drug response 13. Thiopurine side effects 14. Thiopurine toxicity 15. Thiopurine dosing 16. Thiopurine therapy 17. Antimetabolic agents 18. Immunosuppressants 19. Anti-inflammatory drugs.
1. Metastatic colorectal cancer 2. Single agent fluoropyrimidines 3. Reduced efficacy 4. Elderly patients 5. Oxaliplatin-based chemotherapy 6. Quality of life 7. Comparison 8. Chemotherapy 9. Colorectal cancer treatment 10. Fluoropyrimidines vs oxaliplatin 11. Elderly population 12. Oncology 13. Anticancer drugs 14. Clinical trials 15. Outcomes research 16. Cancer therapy 17. Health-related quality of life 18. Cancer survivors 19. Cancer care 20. Clinical studies.
1. Mice 2. Defective 3. Deoxyribonucleic acid (DNA) 4. Deoxyribonucleic acid polymerase I (Pol I) 5. Polymerase I 6. Ionizing radiation 7. Sensitivity 8. Increased sensitivity 9. Genetic mutation 10. DNA replication 11. DNA repair 12. Nucleotide excision repair 13. Double-strand break repair 14. Radiation resistance 15. DNA damage response 16. Ionizing radiation exposure 17. Gene mutation 18. Mouse model 19. DNA synthesis 20. Radioresistance.
1. Mice 2. Interferon 3. Receptor 4. Autoimmune myocarditis 5. Experimental model 6. Resistance 7. High resistance 8. Immunity 9. Interferon deficiency 10. Interferon receptor knockout 11. Myocarditis 12. Immunopathology 13. Infectious agents 14. Cytokines 15. Inflammation 16. Cardiac damage 17. Immunological response 18. Viral myocarditis 19. Genetic modification 20. Immunological susceptibility.
1. Mice 2. IFN (Interferon) 3. IFN receptor 4. Myhc (Myosin Heavy Chain) 5. CFA (Complete Freund's Adjuvant) 6. EAM (Experimental Autoimmune Myocarditis) 7. Resistant 8. Immunity 9. Interferon-free 10. IFN receptor-deficient 11. Myosin 12. Autoimmune disease 13. Adjuvant 14. Immunopathology 15. Myocarditis 16. Resistance mechanism 17. Innate immunity 18. Cytokines 19. Immunological response 20. Experimental model.
1. microRNAs 2. Neural Stem Cells (NSCs) 3. Differentiation 4. Proliferation 5. Neuronal Development 6. Neurogenesis 7. Homeostasis 8. Regulation 9. Epigenetics 10. Gene Expression 11. Post-transcriptional Modification 12. RNA Interference 13. Neuroplasticity 14. Neurogenic Niches 15. Stem Cell Niche 16. Neurogenesis Markers 17. Neural Progenitor Cells 18. Neurogenic Regulation 19. Signal Transduction 20. Developmental Biology.
1. Microarray results 2. Culture amplified mixtures 3. Serotypes 4. Correlate poorly 5. Uncultured mixtures 6. Gene expression 7. Bacterial mixtures 8. Culture conditions 9. Microbial diversity 10. Gene expression profiling 11. Culture techniques 12. Microbial communities 13. Gene expression analysis 14. Amplification processes 15. Microbial identification 16. Culture-dependent methods 17. Culture-independent methods 18. Gene expression patterns 19. Bacterial populations 20. Microbial ecology.
1. Mitochondria 2. Apoptosis 3. Cell death 4. Uninvolved 5. Role 6. Function 7. Mitochondrial dysfunction 8. Apoptotic pathway 9. Caspases 10. Bcl-2 family proteins 11. Mitochondrial outer membrane permeabilization (MOMP) 12. Apoptotic signaling 13. Cell survival 14. Anti-apoptotic proteins 15. Pro-apoptotic proteins 16. Apoptosis initiation 17. Mitochondrial damage 18. Apoptotic mitochondria 19. Apoptotic response 20. Apoptosis regulation.
1. Epigenome 2. Brain 3. Aging process 4. Neurogenesis 5. Gene expression 6. Modification 7. Epigenetic marks 8. DNA methylation 9. Histone modifications 10. Chromatin remodeling 11. Neuronal differentiation 12. Neuroplasticity 13. Aging-related genes 14. Epigenetic clock 15. Epigenetic therapy 16. Epigenetics and aging 17. Neurodegenerative diseases 18. Epigenetic regulation 19. Brain aging 20. Gene regulation in aging.
1. Monoclonal antibody 2. N-cadherin 3. Targeting 4. Metastasis 5. Inhibition 6. Cancer 7. Tumor 8. Immunotherapy 9. Antibody-mediated therapy 10. Adhesion molecules 11. Cell signaling 12. Invasion 13. Molecular targeting 14. Anti-N-cadherin antibody 15. Metastatic cancer 16. Anticancer therapy 17. Epithelial-mesenchymal transition 18. Cell adhesion 19. Antibody binding 20. Cancer metastasis.
1. Termination events 2. Okazaki fragments 3. Sequence specific 4. DNA replication 5. RNA primers 6. Elongation 7. Primer removal 8. DNA polymerase 9. Displacement 10. Nicking 11. Mismatch repair 12. Replication fork 13. DNA synthesis 14. Template switching 15. Proofreading 16. Helicases 17. Single nucleotide mismatches 18. Okazaki joining 19. Polymerase stalling 20. Repair mechanisms.
1. Mutant mice 2. Lacking Svct2 (Sodium-dependent vitamin C transporter 2) 3. Ascorbic acid 4. Increased levels 5. Brain 6. Adrenals 7. Vitamin C transporter 8. Sodium-dependent 9. Metabolic disorder 10. Neurotransmission 11. Antioxidant 12. Oxidative stress 13. Neuroprotection 14. Adrenal glands 15. Vitamin C metabolism 16. Mouse model 17. Genetic modification 18. Biochemistry 19. Nutritional deficiency 20. Health effects.
1. Mutations 2. G beta protein (GNB2) 3. Cancer 4. Loss of interaction 5. G alpha subunits 6. Akt pathway 7. Activation 8. Oncogenic mutations 9. G protein-coupled receptors (GPCRs) 10. Signal transduction 11. Cell signaling 12. Tumor progression 13. G protein complex 14. Receptor activation 15. Intracellular signaling 16. Protein interactions 17. Akt signaling pathway 18. Cellular signaling cascades 19. Neoplasia 20. Malignant transformation 21. G protein-mediated signaling 22. Cellular responses 23. G protein-coupled receptor signaling 24. Akt kinase 25. Phosphorylation 26. Cellular signaling networks 27. Growth factors 28. Cell proliferation 29. Apoptosis 30. Cell survival.
1. N-terminal cleavage 2. Transcription start sites 3. Identification 4. Success rate 5. RNA processing 6. Pre-mRNA 7. Transcription initiation 8. Cap structure 9. 5' end determination 10. Transcript mapping 11. Sequencing techniques 12. Polyadenylation 13. Transcription factors 14. Initiation complex 15. RNA-seq analysis 16. Gene expression 17. Epigenetic modifications 18. Promoter regions 19. Transcriptome analysis 20. Bioinformatics tools.
1. N terminal cleavage 2. Transcription start sites 3. Identification 4. Reduces success 5. RNA processing 6. Pre-mRNA 7. Transcription initiation 8. Cap structure 9. 5' end 10. Transcript mapping 11. Sequencing techniques 12. Gene expression 13. Epigenetic modifications 14. Transcription factors 15. Alternative transcription start sites.
1. N348i mutation 2. Zidovudine resistance 3. AZT resistance 4. Nucleoside reverse transcriptase inhibitor (NRTI) resistance 5. HIV mutations 6. Thymidine analogue mutations (TAMs) 7. Zidovudine-resistant HIV 8. Antiretroviral therapy (ART) resistance 9. Nucleoside analogue resistance 10. HIV drug resistance 11. Nucleotide analogue reverse transcriptase inhibitor (NtRTI) resistance 12. Thymidine analogue mutations in HIV-1 13. N348I substitution 14. Zidovudine-resistant strains 15. HIV-1 drug resistance mutations.
1. NF2 (Neurofibromin 2) 2. Merlin (NM23-H1) 3. Phosphorylation 4. YAP (Yes-associated protein) 5. Cytoplasmic sequestration 6. Drosophila 7. LATS1 (Large tumor suppressor kinase 1) 8. LATS2 (Large tumor suppressor kinase 2) 9. Kinases 10. Tumor suppressor 11. Signal transduction 12. Cellular localization 13. Hippo pathway 14. Phosphorylation cascade 15. Cellular response 16. Regulation 17. Protein interaction 18. Cell fate determination 19. Developmental biology.
1. NF2 (Neurofibromin 2) 2. Merlin (Moesin-Ezrin-Radixin-Like Protein) 3. Phosphorylation 4. YAP (Yes-associated protein) 5. Cytoplasmic sequestration 6. Drosophila melanogaster 7. Neurofibromatosis type 2 8. Protein kinase C 9. RhoGAP (Ras GTPase-activating protein) 10. Signal transduction 11. Subcellular localization 12. Transcriptional regulation 13. Hippo signaling pathway 14. Cellular localization 15. Nuclear translocation 16. Cellular processes 17. Gene expression 18. Protein interactions 19. Intracellular signaling 20. Developmental biology.
1. NFAT4 (Nuclear Factor of Activated T-cells, 4) 2. Activation 3. IP3R (Inositol 1,4,5-triphosphate Receptor) 4. Ca2+ (Calcium Ions) 5. Mobilization 6. Calcium signaling 7. IP3 (Inositol 1,4,5-triphosphate) 8. Second messenger 9. Calcium release 10. Calmodulin 11. Calcium-dependent signaling 12. Intracellular calcium 13. Signal transduction 14. Phospholipids 15. Plasma membrane 16. Calcium channels 17. Calcium binding proteins.
1. Nox2 (NADPH Oxidase 2) 2. Independent pathways 3. Peroxynitrite 4. Nitrogen intermediates 5. Reaction 6. NADPH oxidase 7. Redox reaction 8. Nitric oxide (NO) 9. Superoxide anion (O2-) 10. Nitrite (NO2-) 11. Nitrosyl cation (NO+) 12. Reactive nitrogen species (RNS) 13. Reactive oxygen species (ROS) 14. Nitroxidative stress 15. Nitrosylation 16. S-nitrosylation 17. Nitrite reduction 18. Nitric oxide synthase (NOS) 19. Peroxynitrite formation 20. Nitrosative stress.
1. Nr5a2 gene 2. Endometrial tissues 3. Development 4. Endometrium 5. Differentiation 6. Gene expression 7. Hormone regulation 8. Reproductive system 9. Female reproductive tract 10. Endocrine signaling 11. Steroid hormones 12. Cellular growth 13. Embryogenesis 14. Immunomodulation 15. Fetal development 16. Chromatin remodeling 17. Transcription factors 18. Endometrial stroma 19. Endometrial glands 20. Menstrual cycle.
1. Nanoparticles 2. Targeted delivery 3. Specific cell types 4. Aptamers 5. Lipid nanoparticles 6. Nanotechnology 7. Cellular targeting 8. Bioconjugation 9. Aptamer-lipid nanoparticles 10. Nanomedicine 11. Drug delivery 12. Cellular internalization 13. Cell recognition 14. Biocompatibility 15. Therapeutic applications 16. Targeted drug delivery 17. Nanoscale materials 18. Aptamer-mediated targeting 19. Cellular targeting agents 20. Biological recognition elements.
1. Neutrophils 2. ANCA (Anti-Neutrophil Cytoplasmic Antibodies) 3. Neutrophil Extracellular Traps (NETs) 4. NETosis 5. Stimulation 6. ANCA-stimulated neutrophils 7. Inflammation 8. Immunity 9. Released 10. Extracellular matrices 11. Neutrophil activation 12. NET formation 13. Antibodies 14. Cytoplasmic components 15. DNA 16. Histones 17. Chromatin 18. Biology 19. Immunology 20. Pathology.
1. Tuberculosis 2. New drugs 3. Necrotic portion 4. Lesion 5. Penetration 6. High concentrations 7. Antituberculosis therapy 8. Drug resistance 9. Tuberculous infection 10. Necrosis 11. Drug delivery 12. Pharmacokinetics 13. Tuberculosis treatment 14. Mycobacterium tuberculosis 15. Drug efficacy 16. Bioavailability 17. Tuberculosis research 18. Drug development 19. Tuberculosis therapy 20. Necrotic tissue 21. Drug penetration enhancers 22. Drug design 23. Tuberculosis pathology 24. Tuberculosis diagnosis 25. Tuberculosis treatment options.
1. Non-invasive ventilation (NIV) 2. Conventional treatment 3. Inadequate response 4. Decrease NIV use 5. Respiratory failure 6. Intubation 7. Mechanical ventilation 8. Respiratory distress 9. Critical care 10. Weaning 11. Oxygen therapy 12. Positive pressure ventilation 13. End-of-life care 14. Clinical assessment 15. Respiratory rate 16. Oxygen saturation 17. Work of breathing 18. Comfort measures 19. Patient-ventilator synchrony 20. Clinical judgment.
1. Runx1 gene 2. Normal expression 3. Tumor promoting effects 4. Oncogenic role 5. Transcription factor 6. Cancer development 7. Tumorigenesis 8. Cell growth 9. Apoptosis inhibition 10. Angiogenesis 11. Stem cells 12. Hematopoiesis 13. Leukemia 14. Lymphoma 15. Gene regulation 16. Signal transduction 17. Cell cycle progression 18. Proliferation 19. Differentiation 20. Epigenetic modifications.
1. Obesity 2. Life quality 3. Reduced quality of life 4. Health issues 5. Comorbidities 6. Physical function 7. Mobility 8. Chronic diseases 9. Disability 10. Self-esteem 11. Social isolation 12. Depression 13. Anxiety 14. Sleep apnea 15. Diabetes 16. Hypertension 17. Cardiovascular disease 18. Stroke 19. Joint pain 20. Fatigue 21. Limitations in daily activities 22. Impaired cognitive function 23. Poor nutrition 24. Sedentary lifestyle 25. Weight gain 26. Body mass index (BMI) 27. Health decline 28. Medical complications 29. Health care utilization 30. Obesity-related stigma.
1. Obesity 2. Environmental factors 3. Determinants 4. Nutrition 5. Diet 6. Physical activity 7. Socioeconomic status 8. Culture 9. Food environment 10. Built environment 11. Access to healthy food 12. Urban planning 13. Social norms 14. Education 15. Workplace policies 16. Income inequality 17. Food deserts 18. Sedentary lifestyle 19. Marketing and advertising 20. Public health 21. Environmental justice 22. Obesogenic environment 23. Childhood obesity 24. Adult obesity 25. Prevention strategies 26. Public policy 27. Community interventions 28. Health disparities 29. Environmental health 30. Lifestyle factors.
1. Ribosomes 2. Intronic RNAs (incRNAs) 3. Occupancy 4. Ribosome binding 5. Functional peptides 6. Non-coding RNAs 7. Translation 8. Peptide synthesis 9. Introns 10. RNA binding proteins 11. Translational repression 12. Ribosome stalling 13. Ribosome skipping 14. Ribosome bypass 15. Non-AUG initiation 16. Ribosome scanning 17. Peptide suppression 18. Ribosome drop-off 19. Ribosome pausing 20. Translational elongation.
1. Ribosome occupancy 2. Intronic RNAs (incRNAs) 3. Mirror 5 UTRs (Untranslated Regions) 4. RNA-protein interaction 5. Translation initiation 6. Ribosome binding site 7. 5' UTR (Five prime Untranslated Region) 8. RNA structure 9. RNA folding 10. RNA binding proteins 11. Translation elongation 12. Ribosome stalling 13. Ribosome scanning 14. RNA interference 15. RNA processing 16. RNA metabolism 17. Ribosome profiling 18. Ribosome footprinting 19. RNA sequencing 20. Ribosome occupancy analysis.
1. Omnivores 2. Carnivores (optional, as omnivores consume both meat and plants) 3. Vegetarians 4. Trimethylamine N-oxide (TMAO) 5. Diet 6. Carnitine 7. Digestion 8. Metabolism 9. Intestinal microbiota 10. Food sources (for carnitine) 11. Nutrition 12. Health comparison 13. Vegetarian diet 14. Omnivorous diet 15. Gut bacteria 16. TMAO production 17. Choline 18. Phosphatidylcholine 19. Lipids 20. Cardiovascular health 21. Amino acids 22. Protein sources 23. Meat consumption 24. Plant-based diet 25. Digestive system.
1. Cell survival 2. Cell differentiation 3. Stress resistant spores 4. Minority of cells 5. Development 6. Cell death 7. Spore formation 8. Stress resistance 9. Cell viability 10. Cellular differentiation 11. Survival rate 12. Cellular stress 13. Spore germination 14. Cellular adaptation 15. Cellular resilience 16. Cellular response 17. Cellular durability 18. Cellular protection 19. Cellular tolerance 20. Cellular robustness.
1. PD (Programmed Death) 2. Triggering 3. Monocytes 4. Reduces 5. IL-10 (Interleukin-10) 6. Production 7. Monocyte production 8. Cytokine production 9. Immunology 10. Inflammation 11. Programmed cell death 12. Immunomodulation 13. Mononuclear cells 14. Cytokine signaling 15. Immunoregulation 16. Inflammatory response 17. PD-1 expression 18. Monocyte function 19. Cytokine expression 20. Immunotherapy.
1. PDPN (Podoplanin) 2. Efficient motility 3. Dendritic cells 4. Stromal surfaces 5. C type lectin receptor 6. Actin cytoskeleton 7. Activation 8. Rearrange 9. Signal transduction 10. Cell motility 11. Immunology 12. Lymph nodes 13. Cell adhesion 14. Cell signaling 15. Cytoskeleton dynamics 16. Podosomes 17. Receptor-mediated signaling 18. Actin filaments 19. Cell migration 20. Cell trafficking.
1. PGE2 (Prostaglandin E2) 2. Intestinal tumors 3. Tumor suppressor genes 4. DNA repair genes 5. Altered expression 6. Prostaglandins 7. Inflammation 8. Colorectal cancer 9. Oncogenes 10. Apoptosis (programmed cell death) 11. Gene regulation 12. Tumorigenesis 13. Epigenetics 14. Signal transduction 15. Cyclooxygenase (COX) 16. NF-κB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) 17. p53 (tumor suppressor protein) 18. APC (Adenomatous polyposis coli) 19. BRCA1/BRCA2 (Breast Cancer 1 and 2) 20. Genetic mutations.
1. Pkg-LA (Phosphofructokinase-Liver, Aldolase) 2. Knockout mice 3. Pain hypersensitivity 4. Expression 5. Role 6. Essential function 7. Aldolase 8. Phosphofructokinase 9. Liver 10. Pain perception 11. Sensitization 12. Nociception 13. Analgesia 14. Neurophysiology 15. Animal model 16. Mice 17. Biochemistry 18. Metabolism 19. Fructose-6-phosphate 20. Aldolase reaction 21. Fructose-bisphosphate 22. Pain behavior 23. Neurotransmission 24. Synaptic transmission 25. Pain pathways.
1. PPAR (Peroxisome Proliferator-Activated Receptors) 2. RXRs (Retinoid X Receptors) 3. Inhibition 4. PPAR ligands 5. Peroxisome Proliferators 6. Nuclear Receptors 7. Transcription Factors 8. Agonists 9. Antagonists 10. Receptor Interaction 11. Signal Transduction 12. Pharmacology 13. Drug Interactions 14. Gene Expression 15. Receptor Complexes 16. Coactivators 17. Corepressors 18. Regulation 19. Therapeutic Implications 20. Molecular Mechanisms.
1. PPAR (Peroxisome Proliferator-Activated Receptors) 2. RXRs (Retinoid X Receptors) 3. Activation 4. Ligands 5. Peroxisome Proliferators 6. Nuclear Receptors 7. Transcription Factors 8. Agonists 9. Binding 10. Signal Transduction 11. Gene Expression 12. Regulation 13. PPAR-RXR Heterodimers 14. Nuclear Localization 15. Coactivators 16. Corepressors 17. Thiazolidinediones 18. Fibrates 19. Fatty Acids 20. Diabetes 21. Inflammation 22. Lipid Metabolism 23. Steroid Hormones.
1. Physical activity 2. Six months 3. Cognitive functioning 4. Brain health 5. Neuroplasticity 6. Exercise 7. Aerobic activity 8. Strength training 9. Memory 10. Attention 11. Executive function 12. Mental performance 13. Neurological benefits 14. Fitness 15. Ageing population 16. Dementia prevention 17. Brain health supplement 18. Neuroprotection 19. Cognitive enhancement 20. Long-term effects 21. Regular physical activity 22. Healthy ageing 23. Neuroscience 24. Mental fitness 25. Fitness for the brain.
1. HIV patients 2. Stable partnerships 3. Faster progression 4. HIV to AIDS 5. Relationships 6. HIV disease progression 7. AIDS development 8. Partners 9. HIV treatment 10. Disease progression rate 11. Long-term relationships 12. HIV transmission 13. CD4 count decline 14. Viral load 15. Antiretroviral therapy 16. HIV infection stage 17. Health outcomes 18. HIV care 19. HIV risk factors 20. HIV prognosis.
1. Peroxynitrite 2. Nitration 3. TCR (T-cell Receptor) 4. CD8 (Cluster of Differentiation 8) 5. Reactive Nitrogen Species (RNS) 6. Nitric Oxide (NO) 7. Superoxide 8. Nitric Oxide Synthase (NOS) 9. Nitrotyrosine 10. Protein Nitration 11. Immunity 12. T-cell Signaling 13. Oxidative Stress 14. Nitrosative Stress 15. Nitrosylation 16. Reactive Oxygen Species (ROS) 17. T-cell Activation 18. Nitrite 19. Nitrosylated Peptides 20. Nitro-modified Proteins.
1. Pleiotropic coupling 2. GLP-1R (Glucagon-like peptide-1 receptor) 3. Intracellular effectors 4. Cellular signaling 5. Distinct profiles 6. Receptor activation 7. Second messenger systems 8. Intracellular signaling pathways 9. Signal transduction 10. G protein-coupled receptors (GPCRs) 11. Intracellular signaling proteins 12. Downstream signaling 13. Intracellular cascades 14. Cellular responses 15. GLP-1 (Glucagon-like peptide-1) 16. Intracellular signaling complexes 17. Regulatory proteins 18. Intracellular signaling networks 19. Intracellular signaling machinery 20. Cellular communication.
1. Podocytes 2. Motility 3. Migration 4. Injury 5. Renal cells 6. Kidney 7. Epithelial cells 8. Foot processes 9. Wound healing 10. Regeneration 11. Damage 12. Renal injury 13. Podocyte motility 14. Podocyte migration 15. Cellular response 16. Renal repair 17. Epithelial repair 18. Renal fibrosis 19. Renal disease 20. Cellular movement.
1. Polymeal 2. Nutrition 3. Cardiovascular mortality 4. Reduces risk 5. Heart health 6. Heart disease 7. Mortality rate 8. Clinical trials 9. Cardiovascular events 10. Health benefits 11. Nutritional supplement 12. Cardiovascular disease 13. Health outcomes 14. Life expectancy 15. Nutritional intervention 16. Cardiovascular risk 17. Prevention strategy 18. Nutritional therapy 19. Vital signs 20. Long-term studies.
1. Pretreatment 2. ARP2/3 inhibitor 3. CK 666 4. Lamellipodia 5. Formation 6. Actin cytoskeleton 7. Cell motility 8. Cell shape 9. Rho GTPases 10. F-actin 11. Cell signaling 12. Cytoskeletal dynamics 13. Cell adhesion 14. Cell migration 15. Cell biology 16. Protein inhibition 17. Cellular processes 18. Cellular structure 19. Cellular response 20. Biochemistry.
1. Primary cervical cancer screening 2. HPV (Human Papillomavirus) detection 3. Longitudinal sensitivity 4. Conventional cytology 5. Cervical intraepithelial neoplasia (CIN) 6. Grade 2 7. HPV testing 8. Cervical cancer prevention 9. Sensitivity comparison 10. Cancer screening methods 11. HPV-based screening 12. Cervical precancerous lesions 13. Longitudinal studies 14. Cervical cancer diagnosis 15. HPV co-testing 16. Cervical cancer risk reduction.
1. Primary pro-inflammatory cytokines 2. Secondary pro-inflammatory mediators 3. Secondary anti-inflammatory mediators 4. Cytokine cascade 5. Inflammatory response 6. Immune system 7. Pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) 8. Anti-inflammatory cytokines (IL-4, IL-10, TGF-β) 9. Cytokine network 10. Inflammatory signaling 11. Cytokine release 12. Inflammatory mediators 13. Immune response regulation 14. Inflammation process 15. Cytokine interactions 16. Inflammatory markers 17. Cytokine-mediated communication 18. Inflammatory pathways 19. Inflammatory response modulation 20. Cytokine production.
1. Proteins  2. Synthesized  3. Growth cone  4. Ubiquitinated  5. Higher rate  6. Cell body  7. Protein modification  8. Ubiquitin  9. Neuronal development  10. Neuroplasm  11. Protein turnover  12. Post-translational modification  13. Proteasome  14. Axon growth  15. Dendrite growth  16. Protein trafficking  17. Protein degradation  18. Signal transduction  19. Protein ubiquitination pathway  20. Neuroproteins  21. Neurodegeneration  22. Protein quality control  23. Protein localization  24. Synaptic plasticity  25. Protein function.
1. Pseudogene 2. Ptenp1 3. miRNA (microRNA) 4. RNA (Ribonucleic acid) 5. Regulation 6. Expression 7. PTEN (Phosphatase and tensin homolog) 8. Decoy 9. miRNA binding 10. Post-transcriptional regulation 11. Gene silencing 12. RNA interference 13. Translation inhibition 14. mRNA (Messenger RNA) stability 15. Gene expression 16. Functional pseudogene 17. miRNA target 18. PTEN translation 19. Gene regulation mechanisms 20. RNA binding proteins.
1. Pyridostatin 2. G quadruplex 3. Telomeric region 4. Nucleic acids 5. Quadruple helices 6. Stabilization 7. Destabilization 8. DNA structure 9. Anticancer agents 10. Telomeres 11. G-quartets 12. Groove binding 13. Pyridostatin mechanism 14. G-quadruplex binding 15. Telomeric DNA 16. Anticancer properties 17. Quadruplex destabilization 18. Pyridostatin binding site 19. G-quadruplex structure 20. Telomeric repeat 21. Pyridostatin effect 22. Quadruplex dynamics 23. Telomere maintenance 24. Pyridostatin interaction 25. G-quadruplex unfolding.
1. Radioiodine treatment 2. Non-toxic multinodular goitre 3. Thyroid volume reduction 4. Thyroid gland 5. Iodine-131 6. Hyperthyroidism 7. Hypothyroidism 8. Thyroid nodules 9. Thyroid growth 10. Thyroid shrinkage 11. Endocrine treatment 12. Nuclear medicine 13. Thyroid ablation 14. Thyroid hormone replacement therapy 15. Thyroid function tests 16. Thyroid ultrasound 17. Thyroid surgery alternative 18. Radioiodine therapy indications 19. Thyroid nodule size 20. Thyroid gland function.
1. Rapamycin 2. Fruit flies 3. Triacylglycerols 4. Lipids 5. Metabolism 6. Energy storage 7. Insulin signaling 8. Cellular aging 9. Autophagy 10. Lipid metabolism pathways 11. Adiposity 12. Lipid synthesis 13. Lipid oxidation 14. Lipid storage 15. Mammalian target of rapamycin (mTOR) 16. Gene expression 17. Nutrient sensing 18. Lipid homeostasis 19. Biomarkers 20. Healthy aging.
1. Two-component systems 2. Phosphotransfer rates 3. Rapid phosphotransfer 4. Signal transduction 5. Fidelity 6. Protein kinases 7. Phosphorylation 8. Signal amplification 9. Regulatory proteins 10. Phosphorelay 11. Phosphotransfer cascades 12. Protein phosphorylation 13. Signal processing 14. Receptor kinases 15. Phosphate transfer 16. Kinetics 17. Post-translational modification 18. Cellular signaling 19. Phosphate relay 20. Protein phosphatases.
1. Interferon-induced genes 2. Rapid upregulation 3. Higher basal expression 4. Granule cell neurons 5. West Nile Virus 6. Survival 7. Interferon 8. Neuronal protection 9. Antiviral response 10. Gene expression 11. Viral infection 12. Neuroprotection 13. Interferon signaling 14. Gene regulation 15. Interferon-stimulated genes 16. Neurovirology 17. Immunity 18. Inflammation 19. Apoptosis prevention 20. Neurodegeneration.
1. West Nile Virus (WNV) 2. Granule Cell Neurons 3. Interferon-induced genes 4. Upregulation 5. Basal expression 6. Survival 7. Apoptosis 8. Neuronal damage 9. Inflammation 10. Interferon signaling 11. Interferon response 12. Neurodegeneration 13. Interferon-stimulated genes (ISGs) 14. Antiviral response 15. Neuroinflammation 16. Oxidative stress 17. Proteasome activation 18. Cell death 19. Microglia activation 20. Cytokines 21. Interferon-regulated genes (IRGs) 22. Neuroprotection 23. Viral replication 24. Neuroimmune response.
1. Recurrent mutations 2. CTCF (CCCTC-binding factor) 3. Anchor sites 4. Oncogenes 5. Genetic mutations 6. Frequent occurrence 7. CTCF binding 8. Oncogene regulation 9. Chromatin structure 10. Genomic regions 11. DNA sequence alterations 12. Tumor development 13. Cancer genetics 14. Epigenetic modifications 15. Transcription factors 16. Genomic instability 17. Mutation hotspots 18. Gene expression 19. Cancer biology 20. DNA damage repair.
1. Reduced responsiveness 2. Interleukin 2 (IL-2) 3. Regulatory T cells (Tregs) 4. Autoimmune diseases 5. Type 1 diabetes 6. Immunity 7. Resistance 8. Cytokine signaling 9. T cell function 10. Immunotolerance 11. Autoimmunity 12. Inflammation 13. Immunosuppression 14. Treg development 15. IL-2 receptor 16. T cell activation 17. T cell proliferation 18. T cell survival 19. Treg suppressive function 20. Autoimmune response 21. Immunological self-tolerance.
1. Histone H2A replacement 2. Histone H2Az 3. Nucleosomes 4. Gene activation 5. Yeast 6. Transcription 7. Chromatin structure 8. Epigenetics 9. Histone modification 10. Transcriptional regulation 11. Nucleosome stability 12. Epigenetic marks 13. Transcriptional initiation 14. Histone H2A variants 15. Chromatin remodeling 16. Epigenetic inheritance 17. Transcription factors 18. Gene expression 19. Histone octamer 20. DNA binding.
1. Ribosomopathies 2. Low degree of cell specificity 3. Tissue specific pathology 4. Ribosome biogenesis 5. Ribosome function 6. Cellular homeostasis 7. Protein synthesis 8. Genetic disorders 9. Cellular signaling 10. Apoptosis 11. Cellular stress 12. Cellular response 13. Mutations 14. Ribosomal proteins 15. Ribosome dysfunction 16. Cellular damage 17. Tissue damage 18. Disease progression 19. Therapeutic interventions 20. Cellular repair.
1. S-nitrosylation 2. GAPDH (Glyceraldehyde-3-phosphate dehydrogenase) 3. Histone deacetylases (HDACs) 4. Transnitrosylation 5. Physiological process 6. Post-translational modification 7. Nitric oxide 8. Protein modification 9. Epigenetics 10. Chromatin structure 11. Acetylation 12. Histone tails 13. Enzyme inhibition 14. Signal transduction 15. Redox regulation.
1. Sildenafil 2. Erectile dysfunction 3. SSRI antidepressants 4. Sexual dysfunction 5. Selective serotonin reuptake inhibitors 6. Pharmacological treatment 7. Sildenafil and SSRI antidepressants 8. Erectile function improvement 9. Sildenafil side effects 10. SSRI-induced erectile dysfunction 11. Sildenafil mechanism of action 12. Erectile dysfunction treatment 13. SSRIs and sexual health 14. Sildenafil safety 15. Clinical trials 16. Sildenafil dosage 17. Sildenafil efficacy 18. SSRIs and erectile dysfunction 19. Sildenafil interactions 20. SSRIs and sexual side effects.
1. Bcl-2 protein 2. Tumor maintenance 3. Tumor progression 4. Apoptosis inhibition 5. Anti-apoptotic protein 6. Oncogenesis 7. Cancer cell survival 8. Chemotherapy resistance 9. Tumor suppression 10. Cell death regulation 11. Pro-survival protein 12. Tumorigenesis 13. Apoptotic pathways 14. Cancer cell proliferation 15. Silencing techniques 16. Gene therapy 17. RNA interference 18. siRNA (small interfering RNA) 19. CRISPR-Cas9 system 20. Cancer biology.
1. SMC5 protein 2. Engagement drives 3. Sumo E3 ligase 4. MMS21 protein 5. ATP-dependent remodeling 6. Activation process 7. Protein-protein interaction 8. Sumoylation 9. Post-translational modification 10. E3 ligase complex 11. Remodeling machinery 12. ATP hydrolysis 13. Protein conformational change 14. SUMO conjugation 15. Protein modification pathway.
1. Statins 2. Cholesterol 3. Blood cholesterol 4. Lipid-lowering drugs 5. HMG-CoA reductase inhibitors 6. Hypercholesterolemia 7. Atherosclerosis 8. Cardiovascular disease 9. LDL cholesterol 10. HDL cholesterol 11. Triglycerides 12. Lipid profile 13. Cholesterol reduction 14. Heart health 15. Secondary prevention 16. Primary prevention 17. Side effects 18. Statin therapy 19. Dosage 20. Safety 21. Effectiveness 22. Clinical trials 23. Risk reduction 24. Plaque buildup 25. Coronary artery disease.
1. Statins 2. Cholesterol 3. Blood cholesterol 4. Lipid-lowering drugs 5. Side effects 6. Hypercholesterolemia 7. HDL (good) cholesterol 8. LDL (bad) cholesterol 9. Lipid profile 10. Cholesterol levels 11. Cardiovascular disease 12. Heart health 13. ROS (reactive oxygen species) 14. Inflammation 15. Hepatic metabolism 16. Muscle damage 17. Myopathy 18. Rhabdomyolysis 19. Statin intolerance 20. Statin therapy.
1. Stroke patients 2. In-hospital mortality 3. Direct oral anticoagulants (DOACs) 4. Warfarin 5. Prior use 6. Risk reduction 7. Cardiovascular disease 8. Thromboembolism 9. Anticoagulation therapy 10. Ischemic stroke 11. Hemorrhagic stroke 12. Mortality rate 13. Comparative study 14. Clinical trial 15. Outcomes research 16. Thromboprophylaxis 17. Stroke care 18. Antithrombotic therapy 19. Pharmacology 20. Neurology.
1. Subcutaneous fat 2. Adipose tissue 3. Brown fat (BAT) 4. Cold exposure 5. Non-shivering thermogenesis 6. Adipocytes 7. White adipose tissue (WAT) 8. Beige fat 9. Ucp1 (Uncoupling protein 1) 10. Thermogenesis 11. Cold-induced thermogenesis 12. Adipose browning 13. PPARγ (Peroxisome proliferator-activated receptor gamma) 14. ROS (Reactive oxygen species) 15. Catecholamines 16. Beta-adrenergic receptors 17. Non-esterified fatty acids (NEFAs) 18. Heat production 19. Cold acclimation 20. Energy metabolism.
1. Suboptimal nutrition 2. Chronic disease 3. Predictive factor 4. Nutrition and health 5. Chronic diseases (specific types: diabetes, heart disease, cancer, etc.) 6. Optimal nutrition 7. Health outcomes 8. Nutritional deficiencies 9. Disease risk 10. Epidemiology 11. Healthy diet 12. Nutritional status 13. Chronic conditions 14. Nutrition science 15. Disease prevention 16. Micronutrients 17. Macronutrients 18. Essential nutrients 19. Nutritional balance 20. Public health.
1. Synaptic activity 2. Brain-derived neurotrophic factor (BDNF) 3. Postsynaptic dendrites 4. Neurotrophic factors 5. Synaptic transmission 6. Local release 7. Neuroplasticity 8. Synaptic vesicles 9. Exocytosis 10. Synaptic junction 11. Neuronal communication 12. Post-synaptic receptors 13. Neuronal development 14. Synaptic potentiation 15. Synaptic plasticity 16. Synaptic strengthening 17. Synaptic enhancement 18. Neuromodulation 19. Synaptic signaling 20. Synaptic function.
1. T regulatory cells (Tregs) 2. Lacking V8 (specifically referring to a certain variant or marker of Tregs) 3. Suppressing abilities 4. Pathogenic T cell responses 5. Active inflammation 6. Immunosuppression 7. Autoimmune diseases 8. Inflammatory responses 9. T cell activation 10. Cytokines 11. Immunosuppressive cytokines (such as IL-10, TGF-β) 12. Foxp3 (transcription factor essential for Treg function) 13. Th1 cells (pro-inflammatory T cells) 14. Th2 cells (pro-inflammatory T cells) 15. Th17 cells (pro-inflammatory T cells) 16. Regulatory function 17. Immunological tolerance 18. Homeostasis 19. Inflammation markers 20. Immunotherapies (for treating autoimmune diseases or inflammatory conditions)
1. TCR (T-cell receptor) 2. CD3 microdomains 3. Immunologic synapse 4. T-cell activation 5. Antigen presentation 6. Signal transduction 7. Co-stimulation 8. T-cell receptor complex 9. Cell membrane 10. Protein domains 11. T-cell signaling 12. Immunology 13. Cellular immunity 14. Antigen recognition 15. T-cell response 16. T-cell antigen receptor 17. Microenvironments 18. Membrane proteins 19. Immunological interaction 20. Cellular communication.
1. TNFAIP3 (Tripartite Motif Containing NarF, AlfA and PIAS family member 3) 2. TNFAIP3 gene 3. TNFAIP3 protein 4. Tumor suppressor 5. Glioblastoma 6. Brain tumor 7. Neoplasm 8. Oncology 9. Cancer 10. Apoptosis 11. Inflammation 12. PIAS family 13. Tripartite motif 14. NF-κB signaling 15. TNF-α (Tumor Necrosis Factor-α) 16. Inhibitor 17. Cancer suppression 18. Cell survival 19. Apoptosis regulator 20. Tumor progression.
1. Tocopheryl acetate 2. Vitamin E 3. Prostate cancer 4. Prevention 5. Supplement 6. Dosage 7. 400mg 8. Antioxidant 9. Cancer prevention 10. Prostate health 11. Clinical trials 12. Research 13. Health benefits 14. Vitamin E and prostate cancer 15. Prostate disease 16. Nutritional supplement 17. Cancer risk reduction 18. Vitamin E supplementation 19. Prostate cancer prevention studies.
1. Taxation 2. Sugar-sweetened beverages 3. Type II Diabetes 4. Incidence rate 5. India 6. Public health 7. Prevention 8. Health policy 9. Obesity 10. Nutrition 11. Beverage taxes 12. Diabetes prevention 13. Epidemiology 14. Health economics 15. Sugar consumption 16. Health outcomes 17. Public health interventions 18. Chronic diseases 19. Dietary patterns 20. Health impact assessment.
1. Teaching hospitals 2. Non-teaching hospitals 3. Care quality 4. Patient outcomes 5. Medical education 6. Residency training 7. Clinical experience 8. Doctor experience 9. Patient experience 10. Healthcare facilities 11. Healthcare services 12. Research hospitals 13. Clinical trials 14. Medical staff 15. Patient care 16. Medical standards 17. Healthcare industry 18. Evidence-based medicine 19. Performance metrics 20. Comparative studies.
1. Tetraspanin 3 2. Acute Myelogenous Leukemia (AML) 3. Causative factor 4. Leukemia development 5. Oncology 6. Cancer research 7. Hematology 8. Proteins 9. Membrane proteins 10. Cell signaling 11. Apoptosis 12. Cell proliferation 13. Cancer biology 14. Tumorigenesis 15. Gene expression 16. Molecular biology 17. CD151 (alternative name for Tetraspanin 3) 18. Leukemia stem cells 19. Cancer therapy 20. Drug discovery 21. Biomarkers.
1. DDRB protein 2. Deinococcus radiodurans 3. Alternative single-stranded binding protein (SSB) 4. Single-stranded DNA (ssDNA) binding protein 5. Deinococcal single-stranded DNA binding protein 6. DDRB function 7. DDRB structure 8. Single-stranded DNA protection 9. DNA replication 10. Transcription 11. DNA repair 12. Radiation resistance 13. Thermostability 14. DDRB expression 15. DDRB interaction with DNA 16. DDRB role in DNA metabolism 17. Comparison with canonical SSBs 18. Evolution of alternative SSBs.
1. PPR protein (Pyrazinopterin pyrophosphate synthase) 2. MDA5 (Melanoma differentiation-associated gene 5) 3. N-terminal domains 4. Card domains 5. Pyrophosphate synthase 6. Melanoma differentiation-associated protein 5 7. Protein structure 8. Domain architecture 9. Immunity 10. Interferon production 11. RNA sensing 12. Virus detection 13. Antiviral response 14. Protein-protein interactions 15. Subcellular localization 16. Post-translational modifications 17. Signal transduction 18. RIG-I-like receptors.
1. PRR MDA5 (Pattern Recognition Receptor MDA5) 2. Central domain 3. DEXD helicases 4. RNA helicases 5. Protein structure 6. Domain composition 7. Immunity 8. RNA sensing 9. Interferon production 10. Virus detection 11. RNA binding 12. Nucleotide triphosphatase (NTPase) 13. Helicase activity 14. Double-stranded RNA (dsRNA) 15. Toll-like receptors (TLRs) 16. Innate immunity 17. Interferon-stimulated genes (ISGs) 18. Antiviral response 19. RNA surveillance 20. Inflammation.
1. PRRMDA5 2. Sensor 3. RNA virus 4. Infection 5. Immunity 6. Pathogen detection 7. Interferon response 8. Virus replication 9. RNA binding protein 10. Antiviral defense 11. Innate immunity 12. RIG-I-like receptor 13. Virus detection pathway 14. Nucleic acid sensing 15. Interferon stimulated genes 16. Antiviral response 17. RNA helicase 18. Virus entry 19. Cellular response 20. RNA viruses (specific types if applicable)
1. US Health Care System 2. Kidney Transplants 3. Patients 4. Waiting List 5. National Kidney Paired Donation Program 6. Optimized Program 7. Savings 8. Kidney Transplantation 9. Kidney Donation 10. Kidney Paired Donation 11. Healthcare Costs 12. Transplant Programs 13. National Transplant System 14. Kidney Patients 15. Organ Donation 16. Organ Transplantation 17. Medical Costs 18. Kidney Disease 19. Healthcare Economics 20. Kidney Program Optimization.
1. Yap1 complex 2. Nucleus translocation 3. TEAD proteins 4. Interactions 5. Transcription factors 6. DNA binding proteins 7. Target genes 8. Transcription regulation 9. Nuclear localization 10. Gene expression 11. Chromatin modification 12. Epigenetics 13. Transcriptional co-activators 14. Transcriptional repressors 15. Hydroxylmethylglutaryl-CoA reductase (HMG-CoA reductase) inhibitors 16. Wnt signaling pathway 17. TGF-β signaling pathway 18. Hippo signaling pathway 19. Cell cycle regulation 20. Apoptosis 21. Cellular senescence.
1. DNA data 2. Publicly available 3. Exponential growth 4. Genomic data 5. Sequencing technology 6. Genome projects 7. Doubling time (10 years) 8. Genomic research 9. Bioinformatics 10. Genomic information 11. Genome sequencing 12. Scientific data 13. Genetic data 14. Biotechnology 15. Genomic resources 16. Data expansion 17. Genomic knowledge 18. Genomic innovation 19. Genomic research and development 20. Open access data.
1. Arm density 2. Tatad complexes 3. Class1 Tatad complexes 4. Structural rearrangements 5. Charge zipper mechanism 6. Tat proteins 7. Transcriptional activators 8. DNA binding 9. Protein-protein interactions 10. Electrostatic interactions 11. Charged residues 12. Helix-turn-helix motifs 13. Protein conformation 14. Molecular dynamics 15. Biochemistry 16. Genetics 17. Molecular biology 18. Tat protein structure 19. DNA binding sites 20. Protein-DNA interactions.
1. Safe places to study 2. Homelessness 3. Decreasing homelessness 4. Education 5. Study environments 6. Housing insecurity 7. Academic success 8. Learning opportunities 9. Social services 10. Community resources 11. Student support 12. Study centers 13. Study rooms 14. Access to education 15. Homeless students 16. Affordable housing 17. Educational programs 18. Mental health services 19. Study spaces 20. Academic resources 21. Homeless shelters 22. Educational facilities 23. Study scholarships 24. Homeless outreach 25. Student accommodations 26. Study grants 27. Homeless support services 28. Educational accessibility 29. Study grants for homeless 30. Academic resources for homeless.
1. Homelessness 2. Safe places to study 3. Effectiveness 4. Decreasing homelessness 5. Study environment 6. Housing 7. Shelters 8. Education 9. Access to resources 10. Social services 11. Affordable housing 12. Homeless population 13. Study facilities 14. Public libraries 15. Community centers 16. Learning opportunities 17. Poverty 18. Housing insecurity 19. Mental health 20. Substance abuse 21. Employment opportunities 22. Support services 23. Housing policies 24. Transitional housing 25. Homeless support programs.
1. Colchicine 2. Benefits 3. Secondary prevention 4. Statins 5. High dose statins 6. Widespread use 7. Effective implementation 8. Cardiovascular disease 9. Prevention strategies 10. Risk reduction 11. Anti-inflammatory medication 12. Gout treatment 13. Cardioprotection 14. Reduction in morbidity 15. Mortality rate 16. Atherosclerosis 17. Plaque stabilization 18. Coronary artery disease 19. Stroke prevention 20. Myocardial infarction.
1. ML SA1 activator 2. HTRPML1 3. HTRPML2 4. Binding orientation 5. Protein-protein interaction 6. Receptor binding 7. Activation mechanism 8. Structural differences 9. Conformational changes 10. Ligand binding 11. Molecular dynamics 12. Biochemical interactions 13. Crystal structure 14. Three-dimensional modeling 15. Site-directed mutagenesis 16. Functional assays 17. Molecular docking 18. Computational modeling 19. Biophysical analysis 20. Protein-protein interface.
1. Granuloma 2. Center of granuloma 3. Immune response 4. Pro-inflammatory 5. Immune cells 6. Induces 7. Inflammation 8. Immunity 9. Activation 10. Cytokines 11. Chemokines 12. Antigen presentation 13. T cells 14. Macrophages 15. Dendritic cells 16. Granuloma formation 17. Inflammatory mediators 18. Immune signaling 19. Immune system 20. Granulomatous inflammation.
1. Quiescent hair follicle stem cells 2. H3K4me3 mark 3. H3K79me2 mark 4. Epigenetic modifications 5. Histone modifications 6. Stem cells 7. Quiescence 8. Epigenetics 9. Chromatin structure 10. Hair follicle development 11. Epigenetic marks 12. Transcriptional regulation 13. Epigenetic marks and hair follicle stem cells 14. H3K4me3 and H3K79me2 co-occurrence 15. Epigenetic profile of quiescent hair follicle stem cells 16. Histone modifications in hair follicle stem cells 17. Quiescent hair follicle stem cell epigenome 18. H3K4me3 and H3K79me2 function in hair follicle stem cells.
1. Myosin II isoforms 2. Myosin II b isoform 3. Myosin II a isoform 4. Hematopoietic differentiation 5. Polarizable myosin II 6. Homogenous myosin II 7. Myosin II composition 8. Myosin II switch 9. Myosin II isoform switching 10. Hematopoiesis 11. Myosin II regulation 12. Myosin II structure 13. Myosin II function 14. Cell differentiation 15. Myosin II protein 16. Myosin II isoform identification 17. Myosin II isoform expression 18. Myosin II isoform characterization.
1. Deregulated monocytes 2. Inflammatory diseases 3. Prolonged activation 4. Monocyte deactivation 5. Inflammation 6. Immune response 7. Cytokines 8. Interleukins 9. Tumor necrosis factor-alpha 10. Monocyte chemotactic protein-1 11. Reactive oxygen species 12. Nitric oxide 13. Complement system 14. Acute phase response 15. Chronic inflammation 16. Monocyte subsets (e.g., classical, intermediate, non-classical) 17. Monocyte function impairment 18. Monocyte-derived macrophages 19. Monocyte-derived dendritic cells 20. Monocyte-mediated damage.
1. TMEM27 protein 2. Extracellular domain 3. Human beta cells 4. Protein cleavage 5. Human islets of Langerhans 6. Membrane protein 7. Proteolysis 8. Endoproteases 9. Exoproteases 10. Cell signaling 11. Post-translational modification 12. Protein processing 13. Beta cell function 14. Insulin secretion 15. Diabetes research 16. Protein structure 17. Cleavage site 18. Protein fragments 19. Cellular components 20. Biochemistry.
1. Metastases 2. Genomic aberrations 3. Primary tumor 4. Similarities 5. Mutations 6. Chromosomal alterations 7. Genetic changes 8. Cancer metastasis 9. Tumor genetics 10. Oncology 11. Molecular biology 12. Neoplasms 13. Carcinomas 14. Metastatic spread 15. Genetic markers 16. Tumor progression 17. Cancer metastasis research 18. Genetic profiling 19. Tumor microenvironment 20. Molecular imaging.
1. Locus 2. Colorectal carcinoma 3. Cancer 4. Colorectal cancer 5. Tumor 6. Genetics 7. Mutation 8. Gene 9. Marker 10. Associated genes 11. Risk factor 12. Inherited trait 13. Oncology 14. Genetic marker 15. Loci (plural of locus) 16. Colorectal neoplasms 17. Genetic predisposition 18. Colorectal polyps 19. Adenocarcinoma 20. Genetic testing.
1. Tet protein 2. Loss of function 3. Myeloid cancers 4. Biological consequences 5. Cancer development 6. Tet protein role 7. Myeloid cells 8. Tumor suppression 9. DNA methylation 10. Epigenetic modifications 11. Genetic mutations 12. Carcinogenesis 13. Apoptosis 14. Oncogenesis 15. Cellular growth 16. Cellular differentiation 17. Hematopoiesis 18. Hematological disorders 19. Leukemia 20. Lymphoma.
1. Crohn's disease 2. Foxo3 gene 3. Minor G allele 4. Severe symptoms 5. Genetic marker 6. Foxo3 polymorphism 7. Crohn's disease susceptibility 8. Foxo3 and inflammation 9. Intestinal inflammation 10. Disease progression 11. Foxo3 function 12. Gene variation 13. Genetic association 14. Foxo3 and immune response 15. Crohn's disease pathogenesis 16. Foxo3 and intestinal damage 17. Genetic risk factor 18. Foxo3 and disease activity 19. Foxo3 and intestinal healing.
1. Myocardial lineage 2. Cardiac progenitors 3. Mesodermal origin 4. Heart development 5. Cardiogenesis 5. Mesoderm 6. Cardiac mesoderm 7. Heart tissue 8. Cardiac progenitor cells 9. Heart formation 10. Embryonic development 11. Heart morphogenesis 12. Cardiac differentiation 13. Mesodermal differentiation 14. Cardiac lineage 15. Cardiac development 16. Heart precursor cells 17. Cardiac morphogenesis 18. Cardiac growth 19. Cardiac cells 20. Cardiac developmental biology.
1. One Child Policy 2. Population Growth 3. Population Control 4. Demographic Transition 5. Family Planning 6. Birth Rate 7. Fertility Rate 8. China 9. Population Dynamics 10. Population Reduction 11. Population Management 12. Population Strategy 13. Population Decline 14. Population Stabilization 15. Population Control Measures 16. Population Success Stories 17. Population Trends 18. Population Statistics 19. Population Policy 20. Population Impact.
1. Breast cancer 2. Tamoxifen 3. Metabolism 4. Treatment outcome 5. Genetic make-up 6. Pharmacogenomics 7. Cytochrome P450 enzymes 8. CYP2D6 gene 9. CYP3A4 gene 10. Polymorphisms 11. Drug metabolism 12. Personalized medicine 13. Oncology 14. Pharmacogenetics 15. Breast cancer treatment 16. Genetic testing 17. Patient variability 18. Clinical outcome 19. Therapeutic response 20. Genetic factors.
1. Cas9-induced double strand breaks 2. Human DNA repair 3. Error-prone repair 4. Base substitution errors 5. Insertions and deletions 6. Mismatch repair 7. NHEJ (Non-Homologous End Joining) 8. HR (Homologous Recombination) 9. Microhomology-mediated end joining 10. Single nucleotide variations 11. Indel mutations 12. Genomic instability 13. CRISPR-Cas9 gene editing 14. Off-target effects 15. Mutagenesis 16. DNA damage response 17. DNA repair pathways 18. Genetic modifications 19. Precision genome editing 20. Genetic variants.
1. Breast cancer risk 2. Parous women 3. Placental weight 4. Pregnancies 5. Premenopausal breast cancer 6. Association 7. Increases 8. Placental size 9. Reproductive history 10. Pregnancy history 11. Perinatal factors 12. Estrogen exposure 13. Hormonal influences 14. Fetal growth 15. Maternal health 16. Epidemiology 17. Obstetrics 18. Gynecology 19. Oncology 20. Cancer research.
1. Male prisoners 2. Female prisoners 3. Self-harm 4. Suicide 5. Mental health 6. Prisoners' welfare 7. Risk assessment 8. Prison conditions 9. Depression 10. Anxiety 11. Trauma 12. Self-injury 13. Prison environment 14. Psychological distress 15. Mental health issues 16. Prison population 17. Recidivism 18. Correctional facilities 19. Inmate health 20. Substance abuse 21. Rehabilitation 22. Criminal justice system 23. Prison reform 24. Mental illness 25. Correctional health.
1. Amyloidosis 2. Cardiac involvement 3. Severity 4. Transmurality 5. Late gadolinium enhancement (LGE) 6. Magnetic resonance imaging (MRI) 7. Myocardium 8. Degree 9. Gadolinium contrast agent 10. Cardiac fibrosis 11. Myocardial damage 12. Myocardial scarring 13. Cardiac function 14. Prognosis 15. Heart failure 16. Imaging biomarkers 17. Cardiac amyloidosis 18. Diagnosis 19. Treatment 20. Cardiology.
1. Single flash 2. Evoked ERG (Electroretinogram) 3. B wave 4. On bipolar cells 5. Activity 6. Bipolar cells 7. Visual response 8. Electrophysiology 9. Retina 10. Neuronal response 11. Photoreceptors 12. Rod and cone cells 13. Synaptic transmission 14. Visual pathway 15. Electroretinogram components 16. Light adaptation 17. Dark adaptation 18. Visual processing 19. Electrophysiological tests 20. Vision science.
1. Kinesin 8 protein 2. Kip3 3. Sliding activity 4. Bipolar spindle 5. Spindle assembly 6. Microtubules 7. Motor protein 8. Mitosis 9. Cell division 10. Centrosomes 11. Mitotic spindle 12. Motor function 13. Kinetochore 14. Microtubule dynamics 15. Cell cycle 16. Spindle fiber 17. Motor domain 18. Motor protein complex 19. Mitotic checkpoint 20. Cell polarization.
1. Toxic Type VI Secretion System (T6SS) 2. Inner tube 3. Toxic effector proteins 4. Escherichia coli (E. coli) 5. Antibacterial effector 6. T6SS antibacterial effect 7. Effector proteins 8. Secretion system 9. Type VI secretion system 10. Bacterial warfare 11. Virulence factor 12. Toxins 13. E. coli virulence 14. Secreted effector proteins 15. T6SS machinery 16. T6SS structure 17. T6SS mechanism 18. Bacterial defense 19. Host-pathogen interaction 20. Inner membrane complex.
1. Cancer patients 2. Co ir blockade 3. Treatment 4. Adverse events 5. Autoimmune 6. Side effects 7. Immunotherapy 8. Cancer immunotherapy 9. Co ir inhibitors 10. Safety profile 11. Clinical trials 12. Immunotoxicity 13. Checkpoint inhibitors 14. Cancer immunology 15. Anti-PD-1/PD-L1 therapy 16. Immune response 17. Cancer treatment side effects 18. Co ir blockade mechanism 19. Clinical outcomes 20. Autoimmune disorders 21. Co ir inhibitors safety 22. Cancer immunotherapy safety 23. Co ir blockade toxicity 24. Co ir blockade benefits 25. Co ir blockade efficacy.
1. Cancer patients 2. Coi blockade (Combination of PD-1 and CTLA-4 blockade) 3. Adverse events 4. Autoimmune events 5. Immune response 6. PD-1 (Programmed Death-1) 7. CTLA-4 (Cytotoxic T-lymphocyte-associated protein 4) 8. Immunotherapy 9. Side effects 10. Immune system 11. T-cells 12. Inflammation 13. Immunotoxicity 14. Treatment-related adverse events 15. Complications 16. Immunological reactions 17. Checkpoint inhibitors 18. Oncology 19. Clinical trials 20. Immune-related adverse events.
1. UreABIFG gene cluster 2. Urease maturation proteins 3. UreA, UreB, UreI, UreF, UreG genes 4. Urease enzyme 5. Nitrogen metabolism 6. Urea hydrolysis 7. Urease biosynthesis 8. Urea transport 9. Urease activators 10. Urease regulation 11. Nitrogen fixation 12. Urea cycle 13. Urease inhibitors 14. Microbial urease 15. Gene expression 16. Urease structure 17. Urease function 18. Urease activity 19. Urease catalysis 20. Urease protein structure.
1. Ureabiefgh gene cluster 2. Nickel II ion 3. Gene induction 4. Heavy metal ions 5. Urea biosynthesis 6. Metal homeostasis 7. Gene regulation 8. Transcription factors 9. Promoter region 10. Gene expression 11. Nickel resistance 12. Microbial adaptation 13. Gene clustering 14. Gene function 15. Metal-responsive genes 16. Urea synthesis pathway 17. Genetic regulation 18. Nickel toxicity 19. Gene activation 20. Molecular biology.
1. Dapsone 2. Pyoderma gangrenosum 3. Therapeutic use 4. Anecdotal evidence 5. Treatment 6. Antibiotic 7. Drug therapy 8. Infectious disease 9. Chronic inflammatory condition 10. Wound healing 11. Secondary bacterial infection 12. Leukemia and lymphoma 13. Side effects 14. Clinical experience 15. Case reports 16. Evidence-based medicine 17. Alternative treatments 18. Antibiotic resistance 19. Immunomodulatory effect 20. Dermatology.
1. Hip Fractures 2. Statins 3. Inverse Relationship 4. Medication Use 5. Hip Health 6. Risk Factor 7. Elderly Population 8. Bone Health 9. Cholesterol-lowering Drugs 10. Fracture Prevention 11. Cardiovascular Disease 12. Epidemiology 13. Clinical Trials 14. Pharmacology 15. Hip Injuries 16. Mortality Rates 17. Osteoporosis 18. Hip Replacement 19. Side Effects 20. Cardiovascular Events.
1. HNF4A mutations 2. Diabetes risks 3. No association 4. Genetic variants 5. HNF4A gene 6. Diabetes susceptibility 7. Type 1 diabetes 8. Type 2 diabetes 9. Epidemiology 10. Genetics 11. Diabetes research 12. HNF4A protein 13. Diabetes complications 14. Diabetes prevention 15. Diabetes treatment 16. Population studies 17. Genome-wide association studies 18. Diabetes heritability 19. Single nucleotide polymorphisms 20. Diabetes etiology.
1. Thigh-length compression stockings 2. Graduated compression stockings (GCS) 3. Deep vein thrombosis (DVT) 4. Acute stroke 5. Immobility 6. Hospital patients 7. Prevention 8. Thrombosis 9. Compression 10. Graduated 11. Leg stockings 12. Stroke patients 13. Risk reduction 14. Venous thromboembolism (VTE) 15. Prophylaxis 16. Immobility-related complications 17. Hospitalization 18. Clinical trials 19. Stroke rehabilitation 20. Blood clots.
1. Tirasemtiv  2. Fast twitch muscle 3. No effect 4. Muscle fibers 5. Pharmacology 6. Exercise performance 7. Strength training 8. Contractile properties 9. Myosin ATPase 10. Sarcoplasmic reticulum 11. Calcium release 12. Motor unit recruitment 13. Neuromuscular junction 14. Muscle fiber types 15. Myostatin 16. IGF-1 17. Protein synthesis 18. Muscle hypertrophy 19. Muscle atrophy 20. Clinical trials 21. Pharmacodynamics 22. Myopathy 23. Dystrophies 24. Therapeutic interventions.
1. UCB (Umbilical Cord Blood) 2. T cells 3. Transfer 4. Recipients 5. Memory phenotype 6. Acquire 7. Immunology 8. Immunological memory 9. T cell activation 10. T cell differentiation 11. T cell receptor 12. Antigen presentation 13. Cytokines 14. Homeostatic expansion 15. Proliferation 16. Survival 17. Long-term engagement 18. Effector function 19. Antigen-specific 20. Immunological tolerance 21. Allogeneic transplantation 22. Adaptive immune response 23. Immunological memory cells 24. T cell repertoire 25. Immunological synapse.
1. Transplanted human glial cells 2. Differentiate 3. Host animal 4. Neural stem cells 5. Neurogenesis 6. Neuroplasticity 7. Brain tissue 8. Central nervous system 9. Neuronal differentiation 10. Host-graft interaction 11. Cellular integration 12. Molecular markers 13. Neuroprotection 14. Regenerative medicine 15. Tissue engineering 16. Stem cell therapy 17. Glial cells differentiation 18. Animal model 19. Neurotransmission 20. Synaptic connections.
1. Transplanted human glial progenitor cells 2. Neural network formation 3. Host animals neurons 4. Capable 5. Incapable 6. Glial progenitor cells 7. Neuron interaction 8. Neural integration 9. Brain tissue 10. Neural transplantation 11. Host-graft interaction 12. Synaptic connections 13. Neuroplasticity 14. Brain development 15. Neurogenesis 16. Neuroregeneration 17. Cellular communication 18. Myelination 19. Neuroprotection 20. Brain injury 21. Neurological disorders 22. Neural stem cells 23. Neural differentiation 24. Brain repair 25. Brain function 26. Brain repair strategies.
1. Tumor Necrosis Factor Alpha (TNF-α) 2. Interleukin 1 (IL-1) 3. Pro-inflammatory cytokines 4. Cytokines 5. TNF-α and IL-1 6. Inhibition 7. IL-6 8. IL-10 9. Anti-inflammatory cytokines 10. Immunology 11. Inflammation 12. Cytokine network 13. Immune response 14. TNF-α signaling 15. IL-1 signaling 16. IL-6 suppression 17. IL-10 suppression 18. Inflammatory mediators 19. Immunoregulation 20. Inflammatory diseases.
1. UCB (Umbilical Cord Blood) 2. T cells 3. Transplantation 4. High TCR (T-Cell Receptor) diversity 5. Immunity 6. Reconstitution 7. TCR repertoire 8. T-cell expansion 9. Allogeneic transplant 10. Adaptive immune system 11. TCR gene rearrangement 12. TCR beta chain 13. TCR alpha chain 14. TCR variability 15. TCR selection 16. T-cell survival 17. Immunological memory 18. Hematopoietic stem cells 19. Immunosuppression 20. Graft-versus-host disease.
1. UCB (Umbilical Cord Blood) 2. T cells 3. TCR (T-cell Receptor) 4. Diversity 5. Transplantation 6. Immunity 7. T-cell Repertoire 8. Hematopoietic Stem Cell Transplant 9. Allogeneic Transplant 10. T-cell Expansion 11. Clonal Selection 12. T-cell Proliferation 13. Immunosuppression 14. Graft-versus-Host Disease 15. T-cell Differentiation 16. Thymus 17. T-cell Development 18. T-cell Function 19. Immunological Tolerance 20. T-cell Survival.
1. Ubiquitin ligase 2. UBC13 (ubiquitin conjugating enzyme E2) 3. K63-linked polyubiquitin 4. PCNA (Proliferating Cell Nuclear Antigen) 5. Lysine 164 (K164) 6. Ubiquitination 7. Post-translational modification 8. E2 enzyme 9. Ubiquitin conjugation 10. Protein modification 11. K63 ubiquitin chain 12. Ubiquitin E2 enzyme 13. PCNA ubiquitination 14. Ubiquitin modification at K164 15. UBC13-mediated ubiquitination 16. Ubiquitin transfer 17. Protein ubiquitination 18. Ubiquitin-proteasome system.
1. Ultrasound guidance 2. Needle insertion 3. Traumatic procedures 4. Raises number 5. Significantly 6. Needle placement 7. Sonographic guidance 8. Complications 9. Needle injuries 10. Needle insertion site 11. Image-guided procedures 12. Needle aspiration 13. Needle biopsy 14. Needle puncture 15. Sonography 16. Interventional procedures 17. Needle errors 18. Needle deviations 19. Needle complications 20. Needle misplacements.
1. p53 pathway upregulation 2. p53 tumor suppression 3. Cancer resistance 4. Senescent cells 5. Organismal aging 6. Cellular senescence 7. Oncogenic stress 8. p53 activation 9. Apoptosis inhibition 10. Cell cycle arrest 11. Telomere shortening 12. Oxidative stress 13. DNA damage response 14. Mitochondrial dysfunction 15. Senescence-associated secretory phenotype (SASP) 16. Tumor suppression bypass 17. Cellular senescence in aging and cancer 18. p53-dependent senescence 19. Accelerated aging 20. Lifespan reduction.
1. West Nile Virus 2. Upregulation 3. Mosgctl1 4. Infection 5. Gene Expression 6. Immunology 7. Virus-induced responses 8. Cytokines 9. Interferons 10. Inflammation 11. Immune response 12. Mosgctl1 induction 13. Mosgctl1 regulation 14. Mosgctl1 activation 15. Viral infection 16. Host response 17. Gene regulation 18. Cytokine production 19. Interferon signaling 20. Mosgctl1 function.
1. Varenicline monotherapy 2. Twelve-week treatment 3. Effectiveness 4. Nicotine replacement therapies (NRT) 5. Combination therapy 6. Bupropion 7. Smoking cessation 8. Medication therapy 9. Quit smoking 10. Smoking withdrawal 11. Varenicline dosage 12. NRT types (patch, gum, lozenge, inhaler) 13. Smoking reduction 14. Long-term treatment 15. Clinical trials 16. Randomized controlled trials 17. Smoking abstinence 18. Pharmacotherapy 19. Smoking addiction 20. Evidence-based medicine.
1. Venules 2. Arterioles 3. Lumen diameter 4. Blood vessels 5. Capillaries 6. Vasculature 7. Diameter 8. Blood flow 9. Microcirculation 10. Vessel size 11. Arterial system 12. Venous system 13. Vascular physiology 14. Blood pressure 15. Resistance vessels 16. Capillary beds 17. Blood volume 18. Hemodynamics 19. Peripheral circulation 20. Vascular remodeling.
1. Venules 2. Arterioles 3. Smooth layer 4. Thinner wall 5. Absent smooth muscle 6. Capillaries (as venules are the larger vessels that connect capillaries to veins) 7. Endothelial layer (as venules have a thinner smooth muscle layer, the endothelial layer becomes more prominent) 8. Blood vessels 9. Vascular system 10. Blood flow 11. Vasoconstriction 12. Vasodilation 13. Pericytes (as they are the cells that surround the smooth muscle layer in arterioles, they are less prominent in venules) 14. Blood pressure 15. Microcirculation.
1. Vitamin D deficiency 2. Pregnancy complications 3. Term of delivery 4. Preterm labor 5. Gestational age 6. Fetal growth 7. Birth weight 8. Labor and delivery 9. Vitamin D levels 10. Maternal health 11. Neonatal outcomes 12. Delivery complications 13. Vitamin D supplementation 14. Preeclampsia 15. Vitamin D insufficiency 16. Vitamin D requirement during pregnancy 17. Vitamin D and labor progression 18. Vitamin D and fetal development 19. Vitamin D and birth outcomes 20. Vitamin D and maternal-fetal health.
1. Vitamin D deficiency 2. Birth weight 3. Unrelated 4. Prenatal nutrition 5. Fetal growth 6. Vitamin D levels 7. Birth outcomes 8. Infant health 9. Nutrient deficiencies 10. Pregnancy complications 11. Growth restrictions 12. Vitamin D supplementation 13. Fetal development 14. Perinatal health 15. Epidemiology 16. Clinical studies 17. Birth weight regulation 18. Vitamin D metabolism 19. Public health 20. Nutritional requirements.
1. Women 2. Higher birth weight 3. Breast cancer 4. Risk factor 5. Later in life 6. Infant weight 7. Childbirth 8. Cancer development 9. Predisposition 10. Body weight 11. Obesity 12. Hormonal imbalance 13. Childhood growth 14. Reproductive history 15. Epidemiology 16. Health outcomes 17. Cancer research 18. Medical history 19. Lifetime risk 20. Cancer prevention.
1. APKcz (Apoptosis-inducing kinase 1) 2. Tumor enhancement 3. Glutamine metabolism 4. Apoptosis 5. Kinase 6. Metabolism 7. Glutamine 8. Cell death 9. Cancer 10. Affecting 11. Metabolic pathways 12. Tumor growth 13. Glutamine synthesis 14. Glutamine catabolism 15. Cell signaling 16. Oncology 17. Apoptotic signaling 18. Cancer metabolism 19. Cellular metabolism 20. Tumor microenvironment.
1. CSMA-C (Carrier Sensing Multiple Access with Collision Avoidance) 2. Formation: In the context of CSMA-C, it could refer to the process of organizing nodes into a specific pattern or structure to improve communication. 3. Weak ligand signalling: Signals with lower intensity or strength than usual. 4. CSMA-C enhancement: Improvement in the performance of CSMA-C due to a specific formation. 5. Collision avoidance: A mechanism used in CSMA-C to prevent data collisions during transmission. 6. Carrier sensing: A technique used in CSMA-C to detect the presence of a signal on the communication channel before transmitting data. 7. Communication channel: The medium through which data is transmitted between nodes. 8. Node: A device or system that communicates with other nodes in a network. 9. Signal strength: The intensity or power of a signal. 10. Network: A collection of interconnected nodes that communicate with each other. 11. Performance: The efficiency or effectiveness of a communication system. 12. Data transmission: The process of sending data from one
1. mTORC2 (mammalian target of rapamycin complex 2) 2. Intracellular cysteine levels 3. XCT (xylulose-5-phosphate transporter) 4. Inhibition 5. Regulation 6. Amino acid transport 7. Cysteine homeostasis 8. Metabolic pathways 9. Cell signaling 10. mTOR signaling 11. Xylulose-5-phosphate 12. Metabolic regulation 13. Intracellular metabolism 14. Cysteine metabolism 15. Cellular redox balance 16. Metabolic control 17. Cellular signaling pathways 18. mTORC2-dependent signaling 19. Cysteine transport 20. Cellular metabolism.
1. P16ink4a 2. Accumulation 3. Abnormal wound response 4. Advanced oral potentially malignant lesions (OPMLs) 5. Microinvasive step 6. Wound healing 7. Oncogenes 8. Tumor suppressor genes 9. Cell cycle regulation 10. Apoptosis 11. Inflammation 12. Epithelial dysplasia 13. Carcinogenesis 14. Oral cancer 15. Malignant transformation 16. Cell proliferation 17. Senescence 18. Biomarkers 19. Diagnosis 20. Treatment.
